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1. Introduction 
 
1.1 The mononuclear phagocyte system 
 
Phagocytic cells were in the past classified as the reticuloendothelial system, but this 
system did not distinguish between endothelial cells and macrophages (MΦ), so now the 
mononuclear phagocyte system (MPS) classification includes only MΦ and their 
monocyte and lineage precursors [1]. Developing MΦ are first found in the yolk sack, as 
identified by morphological characteristics, as well as macrophage markers. Studies in 
zebrafish have demonstrated that precursor MΦ from yolk differentiate, and emigrate into 
the head mesenchyme and the associated circulation [2]. Later in development, 
hematopoiesis in the fetal liver becomes a source of MΦ which resemble MΦ found in 
adults. Initially hematopoiesis in the liver generates large numbers of MΦ, which are 
present in most organs [1] (Fig. 1).  
The tissue microenvironment can clearly influence the phenotype of tissue resident MΦ. 
The heterogeneity reflects the specialization of function that is adopted by MΦ in 
different anatomical locations [1]. Alveolar MΦ with high expression of scavenger and 
pattern recognition receptors [3], gut MΦ from the lamina propria with high bactericidal 
activity but very weak proinflammtory cytokine production [4] or Borowicz-Kupffer cells 
from the liver with high capacity for phagocytosis of complement system coated 
pathogens [5] all have different locations, and very different functions, but probably the 
same precursors. 
Many studies indicate that although monocytes can be precursors for the replenishment of 
tissues resident MΦ, many MΦ might be derived by local proliferation, rather than from 
recruited peripheral monocytes. This local proliferation may play considerable role under 
steady state setting, but under inflammatory conditions, repopulation of tissue resident 
MΦ in inflamed tissues is certainly more dependent on the recruitment of precursor cells 
from the blood [1]. The question, however whether tissue MΦ are derived from a 
particular lineage dedicated only to be precursors for macrophages or rather from a more 
randomly selected circulating monocyte pool has not been clarified. 
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Figure 1. The development and members of the mononuclear phagocyte system. Adapted from Gordon 
and Taylor 2005 [1]. M-CSF-macrophage colony stimulating factor, HSC-hematopoietic stem cell, GM-
CFU-granulocyte/macrophage colony forming unit, M-CFU-macrophage colony forming unit, G-CFU-
granulocyte colony forming unit. In red circles highlighted cells investigates in the study.   
 
1.1.1 Monocytes 
 
Monocytes represent 10% of all leukocytes in human blood, and 4% of all leukocytes in 
mouse blood.  Studying their function in biological processes is a difficult mission, 
because monocytes permanently survey the body environment and react to a variety of 
stimuli [6]. The best known function of monocytes is the ability to be a systemic reservoir 
of myeloid precursor cells for the renewal of some tissue MΦ and antigen presenting 
dendritic cells (DC) [7]. This differentiation of monocytes into DC, however, was studied 
primarily under inflammatory conditions. Another important role for monocytes is 
maintaining blood homeostasis, partly through the elimination of apoptotic cells and 
scavenging of toxic compounds [8], since monocytes are equipped with a wide spectrum 
of scavenger receptors that recognize microorganisms but also lipids of dying cells [9]. 
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Monocytes can produce large amounts of inflammatory mediators that participate in the 
defense against pathogens [9] and in the pathogenesis of several inflammatory diseases, 
such as arthritis and atherosclerosis [10]. 
Mouse peripheral blood monocytes (PBMo) are identified in blood based on FSC/SSC 
(forward/site scatter) profile and the expression of CD115, F4/80 and CD11b. Mouse 
monocytes consist of two main subsets. The “inflammatory” subset expresses Ly6C 
(GR1+), CCR2, L-selectin (CD62) and low level of CX3CR1 [7]. Inflammatory 
monocytes are selectively recruited to inflamed tissue [11] and lymph nodes [12] and 
produce high amounts of tumor necrosis factor (TNF)-α and Interleukin (IL)-1 during 
infection or tissue damage [9, 13]. A second subset of monocytes, often called “resident” 
monocytes is characterized by lack of expression of Ly6C (GR1-), CCR2 and L-selectin, 
and by high expression of CX3CR1, LFA-1 and CD43 [7, 14]. This subset has a longer 
half-life than inflammatory monocytes, and is found in resting, as well as in inflamed 
tissues. 
1.1.2 Monocytes are precursors for lung macrophages and lung dendritic cells 
 
According to present knowledge, most investigators believe that monocytes, many 
subsets of MΦ and DC originate from a common myeloid precursor [15]. Among 
myeloid precursors, the macrophage and dendritic cell precursor (MDP) was identified as 
a subset of bone marrow proliferating cells that gives rise to monocytes, which are an 
intermediate cell type for DC and MΦ, but also generates some of DC subpopulations 
directly [6, 15, 16] (Fig. 2). 
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Figure 2. Differentiation of the macrophage and dendritic cell progenitor and origin of macrophage 
and dendritic cells subsets. Adapted from Auffray et al. 2009 [6]. DC-dendritic cells, HSC-hematopoietic 
stem cell, CMP-common myeloid precursor, GMP-granulocyte/macrophage precursor, MDP-macrophage 
and DC precursor, CDP-common DC precursor, pDC-plasmacytoid dendritic cell. In red frames 
highlighted cells investigated in the study.  
 
 
Peripheral blood monocytes can emigrate from the blood through the endothelial barrier 
into various tissues under both non-inflammatory, steady-state conditions and in response 
to inflammatory stimuli. After extravasation, PBMo rapidly undergo phenotype changes 
and differentiate into cells of the organ resident MPS. In the lung, the GR1+ population of 
PBMo can replenish MΦ and DC [17, 18] (Fig. 3). This highly coordinated process 
implicates close linkage between monocyte trafficking and cellular differentiation, which 
shapes the phenotype of the extravasated cells.  
 
(e.g. lungs) 
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Figure 3. Tissue macrophages and dendritic cells can arise from GR1+ monocytes, but also from 
hematopoietic stem and progenitor cells (HSPC) and granulocytes (PMN); adapted from Auffray et al. 
2009 [6]. In red circles highlighted cells investigates in the study. 
 
Monocyte differentiation has been extensively studied in vitro. Monocytes cultured in 
medium containing macrophage colony-stimulating factor (M-CSF) differentiate into 
MΦ, while in the presence of granulocyte macrophage colony-stimulating factor 
(GM-CSF) and IL-4, monocytes differentiate into DC [19, 20]. Although recent in vivo 
investigations have demonstrated that subsets of PBMo can be precursors for DC and 
MΦ [7, 18], the detailed fate of PBMo once they leave the circulation has not been 
comprehensively addressed. Moreover, while cell recruitment under inflammatory 
conditions has been extensively studied, the tissue migration and differentiation of 
mononuclear phagocytes under non-inflammatory conditions remain poorly understood. 
1.1.3 Alveolar macrophages 
 
Under steady state conditions, alveolar macrophages (AMΦ) represent the majority 
(95%) of leukocytes in the lower respiratory tract. Through the presence of surface 
(e.g. lungs) 
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receptors for numerous ligands and through their large number of secretory products, 
lung MΦ can respond to environmental factors [21]. Alveolar macrophages are avidly 
phagocytic and ingest all types of inhaled particles that reach the alveolar space [22]. 
Alveolar macrophages are key players in controlling pulmonary immune responses [23] 
and depletion of AMΦ leads to a significant increase in the inflammatory response to an 
intratracheally administered antigen [24]. The main role of AMΦ under steady state 
conditions is to maintain the airspace quiescent and preserve the ability of the lung to 
perform gas exchange. Additionally, AMΦ posses the power to reduce the activity, 
proliferation and functions of CD4+ T-cells [25] and can downregulate the antigen 
presentation capacity of pulmonary DC [26]. In addition, AMΦ also play an important 
role in inflammatory processes through the release of oxygen radicals and proteolytic 
enzymes. However, when AMΦ are exposed to large numbers of pathogens or pathogen-
derived products and components, such as LPS, AMΦ can initiate a strong inflammatory 
response involving the release of cytokines including TNF-α, IL-1β or IL-6, as well as 
the chemokines CCL2 and CCL5, thereby recruiting monocytes and neutrophils [27]. 
Through the release of several cytokines and growth factors, AMΦ may also influence 
both matrix damage and repair processes [28]. 
 
1.1.4 Lung dendritic cells 
 
Mouse lung DC all express CD11c and exhibit low autofluorescence, in contrast to the 
highly autofluorescent aMΦ [29]; having different anatomical locations in the lung, DC 
reside in conducting airways, lung parenchyma and the alveolar compartment and pleura 
[30]. The trachea and large conducting airways contain intraepithelial DC expressing 
CD103, but not CD11b (which is a myeloid cell marker), while in the sub-mucosa of the 
conducting airways CD103- and CD11b+ DC can be found [31]. In the lung interstitium, 
both mentioned lung DC subpopulations are found. The plasmacytoid DC (pDC) are 
CD11b- but express Siglec-H. Although pDC are present in small amounts in different 
airway compartments, the vast majority reside in central lymphoid organs [32]. During 
lung inflammation there is a recruitment of CD11b+ DC expressing Ly6C, illustrating 
their recent descent of monocytic precursors [33]. 
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The main task of DC is the continuous surveillance of antigen exposed sites, and deciding 
whether to present sampled antigen in an immunogenic or tolerogenic way. These 
circumstances are especially important in the lung, where the interface between epithelial 
cells and the external environment is the largest in the body, and where strong immune 
responses may have devastating effects on fragile gas exchange structures [34]. 
Even in the absence of inflammation DC or their precursors are continuously recruited 
from the blood into the lung [34]. Holt and coworkers [35] were the first to demonstrate 
that pulmonary DC are constantly replenished by steady state bone marrow output. 
Inflammatory stimuli in the inhaled air have a profound impact on these steady state 
dynamics. Dendritic cell recruitment after inhalation of pathogenic material is very rapid, 
in some cases, ahead of neutrophil influx [36], and is an integral part of the early phase of 
the innate immune response, with the potential to progress toward a powerful adaptive 
defense [34].     
 
1.1.5 Lung macrophages and dendritic cells have different functions and location in 
the lung 
 
In the lung, cells of the MPS are key players in host defense and immunological 
homeostasis. While lung MΦ are generally present in both the lung interstitium and 
alveolar airspaces, DC are located primarily within the interstitium, with only a minor 
proportion found in the respiratory tract surface areas [34, 37] (Fig.4). In addition to their 
different localization, lung MΦ and DC fulfill distinct and specialized roles in the 
immune response, which correlate with their different migration properties and cellular 
phenotypes. In the absence of inflammatory stimuli, DC have a much shorter half-life in 
the lung compared to AMΦ [38]. Furthermore, DC do not exhibit impressive phagocytic 
activity, but rather process antigens which are then presented to T cells upon stimulation, 
causing antigen specific T cell priming. To ensure a successful antigen presentation 
to T cells, DC must migrate to the regional lymph nodes. In contrast, lung MΦ are 
considered to form resident cell populations both in the interstitium (interstitial 
macrophages, iMΦ) and in the alveolar airspace (resident alveolar macrophages, rAMΦ), 
where they function as major sentinel and phagocytic populations in the lung, for 
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invading pathogens [39]. Alveolar macrophage and DC precursors must migrate from the 
bloodstream through endothelial and epithelial barriers into the alveolar compartment. 
This journey requires the expression of genes involved in communication with barrier 
structures and rapid adjustment to different oxygen concentrations and osmotic pressures. 
 
 
Figure 4. Localization of dendritic cells and macrophages in the lung. Adapted from Lambrecht and 
Hammad 2003 [40] 
 
1.1.6 Genes involved in the trafficking of mononuclear phagocytes  
 
Trafficking of monocytes into the lung tissue and their differentiation into lung rAMΦ 
and DC is proposed to be regulated by the expression of specific gene clusters, which 
promote cell-cell interaction, migration and matrix degradation, and the acquisition of 
tissue specific cellular phenotypes. Traffic related gene clusters include chemokines, 
integrins, and tissue-degrading matrix metalloproteinase (MMP) enzymes, for all of 
which members have been demonstrated to be functionally important. A complete 
Interstitial DC 
Alveolar macrophage 
Airway DC 
Alveolar DC 
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picture, however, of the gene clusters that are regulated during in vivo migration and 
differentiation of PBMo under non-inflammatory conditions has not yet been obtained. 
Currently, adaptive changes of cellular phenotypes cannot be directly assessed by cell 
fate mapping during the slow trafficking of PBMo to the lung tissue under steady-state 
conditions. An alternative approach to gain a better insight into the genetic programs that 
drive the PBMo migration and differentiation processes would be comparison of the 
transcriptomes of PBMo with their lung tissue mononuclear phagocyte progeny.  
 
1.2 Serotonin 
 
1.2.1 Serotonin as a neurotransmitter 
 
Serotonin (5-hydroxytryptamine, 5-HT) is one of the most extensively studied 
neurotransmitters. It is a monoamine neurotransmitter found in large amounts in the 
gastrointestinal tract of animals. About 80% of the total serotonin is located in the 
enterochromin cells in the gut, and is stored in platelets, which express the serotonin 
reuptake transporter (SERT). In the gut, the 5-HT activity is restricted primarily to the 
regulation of intestinal movements [41]. Serotonin is also synthesized in serotonergic 
neurons in the central nervous system, where it has various functions, including the 
regulation of mood, appetite, sleep, muscle contraction, and some cognitive functions 
including memory and learning [41]. Serotonin is also involved in the regulation of 
diverse cellular processes, such as cell growth and division, cytokine synthesis and 
chemotaxis [41]. 
 
1.2.2 Serotonin and the immune system 
 
Serotonin, apart from being well known for a role in vasoconstriction, has been 
implicated in diverse biological processes such as tissue regeneration [42], platelet 
activation [43], and recently in the immune system regulation [44]. Platelets release 5-HT 
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upon activation in response to vascular wall injury, or LPS [45] or allergen challenge 
[46]. Increased levels of 5-HT in inflammatory processes are well documented [44]. 
Many components of the innate and adaptive immune system have the capability to 
produce, sequester and respond to 5-HT. Activated T-cells [47] and MΦ [48] express 
Thp1, rate limiting enzyme for 5-HT biogenesis, while DC [47], mast cells [49], 
monocytes [50] and MΦ [51] express SERT.  
Serotonin has a well documented effect on cytokine release from blood cells. Dendritic 
cells stimulated with 5-HT increase production of IL-1β and IL-8 and reduce production 
of IL-12 and TNF-α [52]. In human PBMo and human monocytes stimulated with LPS, a 
similar pattern of cytokine release was observed [53, 54]. In addition to cytokine release 
5-HT has been also implicated in the upregulation of phagocytosis by peritoneal MΦ 
[55].  
 
1.2.3 Serotonin receptors in the lung 
 
The broad spectrum of 5-HT action is mediated by a large family of serotonin receptors, 
including ionotropic cation channels (5-HT3) and six types of metabotropic G-protein 
coupled receptors [56]. To the present day, particularly important for the lungs are 5-HT2 
receptors, which are involved in a pathogenesis of pulmonary fibrosis [57] and 
pulmonary hypertension [58].  
The serotonin receptor 5-HT2 class includes 5-HT2A, 5-HT2B, 5-HT2C receptors, which 
are coupled to G proteins. Activation of a receptor initiates signaling cascade resulting in 
the formation of inositol phosphates and elevation of intracellular calcium levels. Many 
inflammatory processes, such as cytokine release, oxidative burst, and interferon 
responses are calcium dependent [59]. While 5-HT2A and 5-HT2B receptors have been 
studied on alveolar epithelial cells, the expression of 5-HT receptors and the effects of 5-
HT on freshly isolated rAMΦ remain elusive.  
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1.3 Granzymes 
 
1.3.1 The Granzyme family  
 
Granzymes are a subfamily of serine proteases, expressed primarily in NK cells and 
CD8+ cytotoxic T-cells. There are 10 granzyme genes in mice (gzmA, gzmB-G, gzmK, 
gzmM, gzmN) and five genes in humans (gzmA, gzmB, gzmK, gzm H and gzmM) [60]. 
Although the first molecular target identified for granzymes was an extracellular protein 
[61], the capacity of granzymes to induce target cell death is now considered as their 
main function, and is most extensively studied.  
Since granzyme expression is restricted primarily to cytotoxic lymphocytes, the role of 
granzyme has been mainly investigated in host defense and the eradication of virally 
infected and malignant cells. Major component of cytotoxic granules produced by 
cytotoxic lymphocytes are granzymes A and B and perforin, which is essential for 
granule release. Cytotoxic cells kill target cells by releasing granules, which cause rapid 
induction of apoptosis by DNA damage, disruption of mitochondrial membrane potential, 
and prevents the cell from repairing the damage it has caused [62].   
 
1.3.2 Non-apoptotic roles of granzymes A and B in immune cells 
 
Recently, many have clarified that, while intracellular targets for granzymes are 
important and have attracted much attention, new non-death related functions for 
granzymes should be proposed and investigated [63-66] (Fig. 5). Apart from the 
induction of cell death, granzymes are important for diverse biological processes, such as 
stimulation of proinflamatory cytokines, remodeling of the extracellular matrix (ECM) or 
inactivation of intracellular pathogens. Recent reports demonstrate that granzyme A and 
B expression is not restricted to cytotoxic and lymphoid cells. Granzyme B was found in 
human plasmacytoid dendritic cells [67], human blood basophils [68], and human and 
mouse mast cells [69, 70]. It is also clear from in vitro data that granzyme B can 
participate in ECM remodeling by cleavage of vitronectin, fibronectin and laminin [71]. 
Granzyme B can also cleave viral proteins, which can cause, for example, attenuation of 
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herpes simplex virus-1 reactivation without killing the infected cells [72]. Granzyme A, 
apart from cleaving ECM proteins [73], can also induce a proinflammatory cytokine 
response, to such a extent that gzmA knockout animals resist the lethal effects of LPS  
[74].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Mechanisms of granzyme escape into the extracellular environment. Adapted from Buzza 
and Bird 2006 [64]. (1) Escape from immunological synapses during target cell killing, (2) constitutive 
granzyme secretion (3) integrin mediated granzyme release by contact with extracellular matrix (ECM) 
proteins (4) local action of chemokines can induce granzyme release (5) bacteria and bacterial components 
such as LPS as well as proinflammatory cytokines induce granzyme release  
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1.4 Aim of the study 
 
Lung macrophages and lung dendritic cells are believed to originate from the same 
monocytic-like precursor cell from the blood. The structure and functions of these two 
cell types are clearly different, however, because of a lack of one specific marker, it is not 
easy to discriminate between these two cell types in the lung, and study their functions 
separately.  
In the presented study differences between lung alveolar macrophages and lung dendritic 
cells were explored, starting with transcriptomic tools to learn more about macrophage 
and dendritic cell biology, as well as to highlight genes that might be crucial for the 
respective unique phenotypes. 
To investigate this problem in an unbiased manner, a whole scale genome approach was 
conducted in which alveolar macrophages, dendritic cells and putative precursor 
monocytes were compared. Candidate genes were then verified for functional relevance.
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2. Materials and Methods 
 
2.1 Animals 
 
 
Wild-type C57BL/6 mice were purchased from Charles River (Sulzfeld, Germany). 
Animals deficient for the 5-HT2C receptor were generated by Dr. Laurence H. Tecott 
(Department of Psychiatry, University of California, San Francisco, USA) [75] and 
obtained from Dr. Pete Clifton (Department of Psychology, University of Sussex, Falmer, 
Brighton, UK). Animals were kept under conventional conditions and used at 6-12 weeks 
of age. All animal experiments were approved by the local authorities. 
 
2.2 Isolation of peripheral blood monocytes, lung macrophages and 
lung dendritic cells 
 
Mice were sacrificed by an overdose of isoflurane by inhalation (Forene®, Abbott). Blood 
was collected from the vena cava caudalis and aseptically transferred to 15 ml tubes. 
Clotting was prevented by addition of ethylenediaminetetraacetic acid (EDTA). 
Erythrolysis was performed with 10 ml 0.8% ammonium chloride lysis buffer. 
Erythrolysis was stopped by addition of 5 ml of RPMI-1640 medium supplemented with 
10% FCS and L-glutamine, and cells were centrifuged (400 × g, 10 min, 4 °C). The pellet 
was resuspended in 10 ml ammonium chloride buffer, and the procedure was repeated. 
Cells were then washed in 5 ml RPMI-1640 medium supplemented with 10% FCS and  
L-glutamine, resuspended in PBS/2 mM EDTA/0.5% FCS, and stained for flow 
cytometry. Macrophages and DC from lungs were isolated as recently described in detail 
[37, 76]. Briefly, lungs were perfused with 20 ml of sterile HBSS until free of blood by 
visual inspection, then removed and transferred into Petri dishes containing 0.7 mg/ml 
collagenase A (Roche; Germany) and 50 µg/ml DNAse I (Serva; Germany) in         
RPMI-1640 medium. Lungs were minced and cut into small pieces, agitated on a shaker 
(30 min, RT) and then incubated at 37 °C for 30 min in a humidified atmosphere 
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containing 5% CO2. Cell aggregates were dispersed by repeated passage through a 
syringe, and filtered through a 200 µm and a 40 µm cell strainer (BD Biosciences), to 
obtain single cell suspension. Subsequently, cells were rinsed with HBSS and PBS/2 mM 
EDTA/0.5% FCS, followed by incubation with an excess concentration of nonspecific 
IgG (Octagam, Octapharma, Germany) to reduce nonspecific antibody binding. After 
washing with PBS/2 mM EDTA/0.5% FCS, cells were stained with magnetic bead-
conjugated anti-CD11c antibodies (Miltenyi Biotec) followed by a magnetic separation 
according to the manufacturer's instructions. Subsequently, the cell population 
(containing CD11c positive cells) was stained with CD11c-PE conjugated antibodies 
(BD Pharmingen) and sorted. To obtain rAMΦ, bronchoalveolar lavage fluid (BALF) 
was performed with 500 µl aliquots of sterile PBS/2 mM EDTA (pH 7.2) until a BALF 
volume of 5 ml was recovered following previously described protocols [77]. The BALF 
was centrifuged (400 × g, 10 min, 4 °C); the cell pellet was resuspended in PBS/2 mM 
EDTA/0.5% FCS, stained with CD11c PE conjugated antibodies (BD Pharmingen) and 
subjected to sorting. 
2.3 Intratracheal LPS installation 
 
Mice were sedated with xylazine hydrochloride (2.5 mg/kg, intramuscular injection) and 
ketamine hydrochloride (50 mg/kg), followed by fur/skin disinfection and subsequent 
shaving of the area above the trachea. A small incision was made and surrounding tissue 
bluntly dissected to expose the trachea. An Abbocath catheter was inserted in the trachea 
and subsequently LPS (10 µg/mouse) dissolved in sterile PBS in a total volume of 70 µl 
was slowly instilled, under stereomicroscopic control. Subsequently, the skin was sutured 
and mice were left to recover from anesthesia and then returned to their cages, with free 
access to food and water. 
2.4 Pappenheim-stained cytocentrifuge preparations 
 
For identification of flow-sorted subpopulations in samples Pappenheim staining of 
cytocentrifuge preparations were used. Briefly, cytospins were prepared from every flow 
sorted sample, containing 30000-50000 cells in 100 µl, and subsequently stained for 
5 min in May-Grünwald stain, washed with distilled water and stained for 10 min in 5% 
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of Giemsa Azur-Eosin-Methylen Blue solution. Total rAMΦ, lung DC and PBMo were 
determined by differential cell counts using overall morphological criteria, including 
differences in cells size and shape of nuclei, the purity of the cells was always >95%. 
2.5 Gene expression analysis 
2.5.1 RNA isolation 
After sorting, cells were frozen at -80 °C in RLT lysis buffer (Qiagen) supplemented with   
1% β-mercaptoethanol (Sigma). The RNA from highly purified cell populations was 
isolated using an RNeasy Micro Kit (Qiagen) according to the manufacturer instructions. 
RNA from cell cultures, where there was no limitation with cell number, was isolated 
from the RNeasy Mini Kit (Qiagen). Quantification and purity of RNA was determined 
with an Agilent Bioanalyzer 2100 (Agilent Biosystems). Only those RNA preparations 
exceeding absorbance ratios of A260/280 nm > 1.90 and of a total amount of RNA greater 
than 200 ng were used for cDNA synthesis. 
 2.5.2 cDNA synthesis 
After isolation, purified mRNA was transcribed into cDNA by reverse transcriptase (RT)-
reaction. To perform cDNA synthesis, RNA was heated for 5 min at 70 °C, immediately 
thereafter transferred onto ice, and RT mix was added. The total reaction volume was 
25 µl. The mixture was then incubated for 1 h at 37 °C, heated on 94 °C for 7 min to 
inactivate the enzyme. The obtained cDNA was then either used for real-time PCR or 
stored at -20 °C until further use. 
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 RT mix:  
• 5× 1st stand buffer  5 µl 
• dithiothreitol (DDT) 2.5 µl  (250 nmol) 
• Rnase Inhibitor 0.5 µl  (20 U) 
• dNTPs   1 µl  (2.5 nmol) 
• random hexamers 1.5 µl  (150 ng) 
• RT (MMLV)  1 µl  (150 U) 
 
2.5.3 Real time quantitative PCR  
 
Quantitative gene expression analysis was performed by real time quantitative PCR 
(qPCR), using Platinum SYBR®Green qPCR SuperMix-UDG (Invitrogen, UK). The 
ROX reference dye was used to normalize the fluorescent signal between reactions. PCR 
reactions were performed in 25 µl volume by using the qPCR mix. 
 
qPCR mix: 
 
• SYBR®Green mix 13 µl 
• MgCl2   1 µl  (50 nmol) 
• FW primer  0.5 µl  (5 pmol) 
• RV primer  0.5 µl  (5 pmol) 
• dH2O   5 µl 
• cDNA   5 µl 
 
Cycling conditions were as follows: 95 °C for 5 min, 45 cycles of 95 °C for 10 s, 60 °C 
for 30 s and 72 °C for 10 s. Formation of a single specific PCR product was confirmed by 
melting curve analysis and agarose gel electrophoresis.  
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The actb, gapdh and hmbs genes served as reference genes for different real-time PCR 
reactions, depending on the type of the experiment performed. Relative changes in gene 
expression were determined with the ∆Ct method using the following formula: ∆Ct = Ct 
reference – Ct target.  
The primers used for qPCR were designed with the help of the online program Primer3 
(http://frodo.wi.mit.edu/primer3/). All primer sequences used throughout the study are 
listed in the Appendix section (7.3). 
 
2.5.4 Microarray experiment 
 
Microarray experiment (outline illustrated in Fig. 6), namely cDNA synthesis, RNA 
amplification, labeling and purification reaction, as well as hybridization were performed 
according to the manufacturer’s instructions (Agilent Technologies, CA, USA).  
Briefly, isolated RNA was transcribed to cDNA as described above. Freshly transcribed 
cDNA was incubated for 5 min on ice, spun down and added to Transcription Master 
Mix. Samples were mixed gently and incubated for 2 h at 40 °C. 
 
 
 
Transcription Master Mix 
 
• dH2O    15.3 µl 
• 4× Transcription buffer  20 µl 
• 0.1M DTT   6 µl 
• NTP mix   8 µl 
• 50% PEG   6.4 µl 
• RNaseOUT   0.5 µl 
• Inorganic pyrophosphatase 0.6 µl 
• T7 RNA polymerase  0.8 µl 
• Cy 3-CTP or Cy 5-CTP 2.4 µl 
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Figure 6. Generation of labeled RNA for two-color microarray experiment. Adapted from the Agilent 
Technologies protocol ”Two color microarray-based gene expression analysis” version 5.7. cDNA-
complementary DNA, cRNA-complementary RNA, Cy-cyanine, MMLV-moloney murine leukemia virus, 
RT-reverse transcription . One RNA sample was labeled with Cy5 (A) and second with Cy3 (B). Samples 
were mixed and spotted on the microarray to perform hybridization.  
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Labeled RNA was transferred into spin columns from RNeasy kit (Qiagen) and purified 
according to the manufacturer’s instructions. After the purification procedure 
concentration, quality (RNA absorbance ratio measured at 260/280 nm) and degree of 
incorporation of fluorescent dyes (Cyanine 3-labeled and Cyanine 5-labeled 
concentration) was recorded by spectrophotometer (Agilent Bioanalyzer 2100, Agilent, 
Germany). Samples were added to the Fragmentation buffer (Agilent Technologies) and 
incubated for 30 min at 60 °C to fragment labeled RNA. Samples were immediately 
thereafter transferred to the Hybridization buffer (Agilent Technologies) and 
subsequently slowly dispensed on the gasket slide that was covered with array forming a 
sandwich that was closed in a chamber in which hybridization took place for 17 h at      
60 °C. Next day the chamber was dissembled and array was washed two times and dried 
by submerging in acetonitrile. Array slides were scanned directly to minimize the impact 
of environmental oxidants on signal intensities. Data from the scanned array was 
extracted to measured gene expression in the experiments by the Agilent Feature 
Extraction software.       
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2.6 Protein expression analysis 
 
2.6.1 Western blot 
 
Cells were lysed with lysis buffer containing 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM 
EDTA (pH 8.0), 1 mM EGTA (pH 8.0), 0.5% NP-40, 2 mM sodium orthovanadate          
(pH 10.0), and protease inhibitor cocktail (Roche, Mannheim, Germany). The lysates 
were kept on ice for 30 min, followed by centrifugation for 15 min at 13,000 rpm at 4°C. 
Proteins were separated by electrophoresis on 10% SDS PAGE under reducing and 
denaturating conditions. Subsequently proteins were transferred to polyvinylidene 
difluoride membranes (Micron Separations, Westborough, MA). After transfer 
membranes were incubated in blocking buffer (5% nonfat milk in PBS, 0.05% Tween 20) 
at room temperature for 1 hour. Primary antibodies were added, and membranes were 
incubated overnight at 4 °C, washed three times, and incubated with horseradish 
peroxidase-conjugated secondary antibody (Pierce, Rockford, IL). After subsequent three 
washes, an enhanced chemiluminescence system was used to visualize immune 
complexes (Amersham Pharmacia Biotech, Little Chalfont, Buckinghamshire, UK).  
 
Loading Buffer 
50 mM Tris Cl (pH 6.8), 100 mM DTT, 2% SDS (10%) glycerol, 0.1% bromophenol 
blue 
 
Electrophoresis buffer mix 
(5x Solution) 
• 25 mM Tris   15.1 g     
• 250 mM glycine  94 g     
• 0.1% (v/v) SDS 50 ml (10%)   
• dH2O   1000 ml   
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Gel electrophoresis conditions 
80 V, 40 mA for 2.5 h 
 
Transfer Buffer (blotting) 
• 25 mM Tris  3.02 g 
• 192 mM glycine 14.4 g 
• 20% methanol  200 ml 
• dH20   up to1000 ml 
 
Wet blotting conditions 
100 V, 265 mA 1 h, with mixing, at 4 °C 
 
Washing Buffer  
0.05%  Tween 20 (2.5 ml) in PBS  
 
Blocking Buffer 
5% Milk powder diluted in Washing Buffer 
 
Developing mix 
Mix reagents 2 ml Solution A, to 50 µl Solution B per membrane for 3 min.  
2.6.2 Flow cytometric analysis and flow sorting 
For staining for flow cytometric analysis and flow sorting, single cell suspensions were 
resuspended in PBS/2 mM EDTA/0.5% FCS. Cell numbers were assessed using a 
Neubauer chamber. Fc-receptor-mediated and non-specific antibody binding was blocked 
by addition of excess of non-specific immunoglobulin (Octagam®, Octapharma, 
Germany). 
Staining was performed at 4 °C in the dark for 20 min. After staining, cells were washed 
twice in PBS/2 mM EDTA/0.5% FCS. Biotinylated primary antibodies were further 
incubated for 5 min with APC-conjugated streptavidin (BD Pharmingen) followed by two 
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additional washes with PBS/2 mM EDTA/0.5% FCS. Cell sorting was performed with a 
FACSVantage SE flow cytometer equipped with a DiVA sort option and an argon-ion 
laser at 488 nm excitation wavelength and a laser output of 200 mW (BD Biosciences). A 
FACSCanto flow cytometer (BD Biosciences) was used for flow cytometric 
characterization of cell populations. The BD FACSDiVa software package was used for 
data analysis (BD Biosciences). Purity of sorted cells was ≥ 98% as determined by flow 
cytometry and differential cell counts of Pappenheim (May-Grünwald-Giemsa)-stained 
cytospins. 
The following monoclonal antibodies were used at appropriate dilutions for staining: 
CD11c-PE and -APC (HL3, BD Pharmingen), CD11b-FITC, -APC, and -PE (M1/70, BD 
Pharmingen), CD115-PE (604 B5 2EII, Serotec), GR-1-PE-Cy7 and -PE (RB6-8C5, 
Biolegend), F4/80-PE (CI:A3-1, Serotec), biotinylated I-A/I-E (2G9, BD Pharmingen), 
CD3-PE (17A2, BD Pharmingen), CD19-PE (1D3, BD Pharmingen), NK-1.1-PE 
(PK136, BD Pharmingen), CD80-PE (1G10, BD Pharmingen), CD86-PE (GL1, BD 
Pharmingen), B220-PE (RA3-6B2, BD Pharmingen), CD49d-PE (R1-2, Biolegend), 
CD103-PE (2E7, Biolegend), CD61-PE (2C9G2, Biolegend), Integrin β7 (FIB504, 
Biolegend). 
2.6.3 Enzyme-linked immunosorbent assay  
Cytokine levels of CCL2 in cell culture supernatants were measured using commercially 
available sandwich enzyme-linked immunosorbent assay (ELISA) kit following the 
instructions of the manufacturer (R&D Systems, Minneapolis, MN). Standards, control, 
and samples were pipetted into the wells, incubated for 2 h at room temperature (RT), 
followed by five washing steps with an ELISA autowasher. After 2 h of incubation with 
the conjugate solution and repetitive washing, substrate solution was added to each well 
for 30 min, and then the reaction was stopped. The optical density was measured using a 
microplate reader set at 450 nm; the sample values were read off the standard curve. The 
detection limit for CCL2 was 2 pg/ml. 
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2.6.4 Fluorescent substrate activity assay 
Granzyme B activity was measured from flow-sorted cells cultured for 24 h in the 
presence or absence of LPS. For the measurement cell culture supernatant, as well as cell 
lysates were collected. Granzyme B fluorescent substrate (Calbiochem, Germany) was 
added to samples for 30 seconds after which the reaction was stopped by addition of 
hydrochloride acid to stop granzyme activity. Fluorescent activity was measured using a 
microplate spectrophotometer (Becton Dickinson, USA) set at wavelength tailored to 
each substrate. 
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3. Results 
 
3.1 Immunophenotypic identification and high purity isolation of 
peripheral blood monocytes, lung dendritic cells and lung 
macrophages 
 
For high purity sorting, PBMo were identified as SSClow, CD11bpos, M-CSF 
receptor/CD115pos cells, following previously reported protocols [14] (Fig. 7A). The cells 
defined by this approach homogenously expressed the monocyte marker F4/80, and were 
partially positive for GR-1 and CD11c, with low levels or absence of MHC class II 
expression, thereby exhibiting the typical phenotype of PBMo (Fig. 7C) [14]. In contrast, 
no expression of T cell, B cell or NK cell markers (CD3, CD19, and NK1.1, respectively) 
was detected (Fig. 7B). 
For high purity separation of MΦ and DC from lung homogenates, in a first step the 
CD11cpos cell fraction was isolated from lung homogenates using magnetic bead 
separation as outlined in the Materials and Methods section. Within this cell population, 
lung DC were identified as CD11cpos, low autofluorescent cells in the FL1 channel, while 
lung rMΦ were discriminated as CD11cpos, high FL1 autofluorescent cells (Fig. 8A). 
Further phenotyping of accordingly gated subsets revealed the characteristic marker 
profiles of lung DC and rMΦ, with lung DC displaying a MHC IIhigh CD80low CD86low 
F4/80low phenotype and lung rMΦ displaying a MHC IIlow CD80low CD86neg F4/80pos 
phenotype (Fig. 8B), which were in line with previously published results [37, 76]. Lung 
DC primarily exhibited an immature phenotype, as defined by high expression of MHC 
class II and intermediate expression of the co-stimulatory molecules CD80 and CD86 
(Fig. 8B). Expression neither of CD115 nor of neutrophil, T cell, B cell, or NK cell 
markers was detected (Fig. 8B). The purity of sorted cells used for the microarray 
experiments (PBMo, lung DC and lung MΦ) was assessed by flow cytometry and 
Pappenheim-stained cytospins (Fig. 8C) and was always ≥ 98%. As sample processing 
may alter the gene expression profile of primary cells [78], every effort was made to 
minimize processing time and, where possible, all procedures were performed on ice. 
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Figure 7. Identification and characterization of peripheral blood monocytes by flow cytometry. (A) 
Peripheral blood was obtained from untreated mice as described, subjected to erythrolysis, and analyzed by 
flow cytometry. Peripheral blood monocytes (PBMo) were identified as low side scatter (SSC) cell 
population showing a cell surface expression of CD11b and CD115. (B) The cell surface antigen 
distribution profile of PBMo was characterized by flow cytometry. PBMo were gated as displayed in (A). 
Open histograms indicate specific fluorescence of the respective antigen; shaded histograms represent 
control stained cells. Note that all cells displayed F4/80 expression, but were negative for GR-1, CD3, 
CD19, B220/CD45R, and NK1.1, thus excluding contamination by neutrophils, T cells, B cells, or NK 
cells, respectively. Displayed data are representative of three independent experiments. (C) Pappenheim 
staining of sorted PBMo. Displayed data are representative of 5-6 independent sorting experiments per 
group.    
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Figure 8. Identification and characterization of lung macrophages and dendritic cells by flow 
cytometry. (A) CD11c positive cells were obtained from lung homogenate by magnetic bead isolation, 
stained for CD11c, and analyzed by flow cytometry. Lung dendritic cells (DC) and lung macrophages 
(MΦ) were differentiated by CD11c expression and autofluorescence with lung DC displaying a low 
autofluorescence and lung MΦ displaying a high autofluorescence in the FL1 channel. (B) The cell surface 
antigen distribution profiles of lung MΦ and lung DC were analyzed by flow cytometric analysis. Lung 
MΦ and DC were gated as displayed in (A). Open histograms indicate specific fluorescence of the 
respective antigen; shaded histograms represent control stained cells. Displayed data are representative of 
three independent experiments. (C) Pappenheim staining of sorted lung DC and MΦ. Displayed data are 
representative of 5-6 independent sorting experiments per group. 
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3.2 Differentially expressed genes between peripheral blood monocytes, 
lung dendritic cells and lung macrophages 
 
 
After cell sorting and RNA isolation, gene expression profiles of PBMo, lung DC and 
lung MΦ were compared by microarray experiment on a whole genome scale. For each 
comparison, four hybridizations were performed (Fig. 9). 
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DC
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Figure 9. Microarray experiment design (RNA material pooling strategy and dye switch diagram). 
From each mouse peripheral blood monocytes (PBMo), lung dendritic cells (DC) and lung macrophages 
(MΦ) were isolated. Four mice were used per one array hybridization. In total 12 hybridizations were 
performed with each four comparing PBMo with MΦ, PBMo with DC, and MΦ with DC. To avoid label 
factor (for example interaction of certain gene with a dye) in microarray experiment dye switch was 
performed. In four comparisons between groups, each time two samples were dyed with Cy3 and two times 
with Cy5.     
 
After cell sorting and RNA isolation, gene expression profiles of PBMo, lung DC and 
lung MΦ were compared by microarray experiment on a whole genome scale. For each 
comparison, four hybridizations were performed (Fig. 9). Genes that exhibited a greater 
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than two-fold change in expression were considered as being differentially expressed, as 
described in the Materials and Methods section. Among the genes differentially 
expressed between lung MΦ and PBMo, 1530 genes were up-regulated, and 1440 genes 
were down-regulated. Comparing lung DC and PBMo, 1271 genes were up-regulated, 
and 341 were down-regulated. Furthermore, 832 genes were found to be up-regulated and 
1565 genes down-regulated between lung MΦ and DC. An analysis of the correlation of 
the M values for the regulated genes from the different hybridizations showed a high 
correlation with an average Pearson correlation coefficient of 0.95, indicating a high 
consistency between the four hybridizations per group. In a pathway analysis, using 
Pathway-Express from Onto-Tools, the cell adhesion molecule pathway was the most 
differentially regulated pathway in all comparisons. The antigen presentation and 
processing pathway was the second most differentially regulated pathway comparing 
lung MΦ versus DC and DC versus PBMo (Fig. 11, 12, 13). 
To further analyze and structure the microarray data, and to address the question of which 
gene clusters and cellular pathways are regulated during the extravasations and lung 
tissue differentiation process of mononuclear phagocytes, particular attention was paid to 
genes involved in cell trafficking, namely integrins, MMPs, chemokines and chemokine 
receptors, as well as interleukins and interleukin receptors (Table 1). In order to visualize 
the results, volcano plots were created with depicted genes belonging to each cluster (Fig. 
10). The highlighted genes were validated on independently sorted samples by qRT-PCR 
and demonstrated the same expression trends as the microarray results (Fig.14, 15, 16). It 
must be noted, however, that the log intensity ratios (for example the coefficients 
displayed in Table 1) obtained from the microarray experiments do not directly equal the 
∆Ct values obtained from the qRT-PCR validation. This is a well-known phenomenon, 
and taking place due to factors such as the preamplification procedure itself and the 
limited dynamic range of fluorescence detection [79, 80]. Due to this fact, ∆Ct values 
obtained from the qRT-PCR analysis were often found to be higher than the coefficients 
for the same genes obtained from the microarray analysis. Likewise, by qRT-PCR 
analysis, there were significant expression differences detectable in certain genes that had 
not been detected by the microarray experiments (Table 1 and Fig. 14, 15, 16). 
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Table 1. Most strongly and significantly regulated genes belonging to selected clusters
Genes were selected to keep a false-discovery rate of 10%. The coefficient given for expression differences corresponds to log(2) of fold change with a
coefficient >0 indicating upregulation and a coefficient <0 indicating downregulation of the respective gene. Lack of given value (indicated as ND) indicates 
either lack of differential regulation or absence of expression. 
gene symbol gene description coefficient
chemokine/chemokine receptor MΦ vs PBMo DC vs PBMo MΦ vs DC
Cxcl1 chemokine (C-X-C motif) ligand 1, [NM_008176] 5,69 4,45 ND
Cxcl2 chemokine (C-X-C motif) ligand 2, [NM_009140] 4,76 ND ND
Cx3cl1 chemokine (C-X3-C motif) ligand 1,  [NM_009142] 4,09 4,37 ND
Ccl6 chemokine (C-C motif) ligand 6, [NM_009139] 2,70 ND 2,6
Ccl17 chemokine (C-C motif) ligand 17, [NM_011332] 2,68 4,38 ND
Ccrl2 chemokine (C-C motif) receptor-like 2, [NM_017466] 2,35 ND ND
Ccl3 chemokine (C-C motif) ligand 3, [NM_011337] 2,25 ND ND
Cxcl10 chemokine (C-X-C motif) ligand 10,  [NM_021274] 2,06 ND ND
Ccl2 chemokine (C-C motif) ligand 2, [NM_011333] 2,04 2,44 ND
Ccl9 chemokine (C-C motif) ligand 9, NM_011338] -2,07 ND ND
Cxcl4 chemokine (C-X-C motif) ligand 4, [NM_019932] -2,38 ND -2,8
Cx3cr1 chemokine (C-X3-C) receptor 1, [NM_009987] -3,36 ND -2,7
Ccl5 chemokine (C-C motif) ligand 5, [NM_013653] -3,72 ND -5,9
Cxcl7 chemokine (C-X-C motif) ligand 7, [NM_023785] -4,68 -3,42 ND
Ccr2 chemokine (C-C motif) receptor 2, [NM_009915] -4,70 -2,04 -2,7
Ccr7 chemokine (C-C motif) receptor 7, [NM_007719] ND 4,61 -4,4
Cxcl16 chemokine (C-X-C motif) ligand 16, [NM_023158] ND 4,17 -2,6
Ccl4 chemokine (C-C motif) ligand 4, [NM_013652] ND 4,09 -3,3
Ccl12 chemokine (C-C motif) ligand 12, [NM_011331] ND 2,72 ND
Cxcr3 chemokine (C-X-C motif) receptor 3, [NM_009910] ND 2,55 -4,2
Cxcr4 chemokine (C-X-C motif) receptor 4, [NM_009911] ND 2,51 -2,6
Ccr9 chemokine (C-C motif) receptor 9, [NM_009913] ND 2,45 -2,5
Ccl7 chemokine (C-C motif) ligand 7, [NM_013654] ND 2,26 ND
Cxcr6 chemokine (C-X-C motif) receptor 6, [NM_030712] ND ND -2,6
                
interleukin/interleukin receptor
Il1a interleukin 1 alpha, [NM_010554] 4,21 2,25 2,2
Il6 interleukin 6, [NM_031168] 4,18 ND ND
Il18 interleukin 18, [NM_008360] 3,04 ND 2,6
Il17d interleukin 17D, [NM_145837] 2,69 ND ND
Il1b interleukin 1 beta, [NM_008361] 2,18 3,84 ND
Il11ra1 interleukin 11 receptor, alpha chain 1, [NM_010549] 2,09 ND ND
Il2rb interleukin 2 receptor, beta chain, [NM_008368] -3,14 ND -5,1
Il12b interleukin 12b, [NM_008352] ND 3,92 -2,5
Il7r interleukin 7 receptor, [NM_008372] ND 2,87 -2,7
Il6 interleukin 6, [NM_031168] ND 2,82 ND
Il18r1 interleukin 18 receptor 1, [NM_008365] ND ND -3,3
metallopeptidases
Mmp19 matrix metallopeptidase 19, [NM_021412] 1,99 ND 2,0
Mmp13 matrix metallopeptidase 13, [NM_008607] ND 3,81 ND
Adam23 disintegrin and metallopeptidase domain 23, [NM_011780] ND 3,02 ND
Mmp14 matrix metallopeptidase 14, [NM_008608] ND 2,61 -2,6
Adam8 disintegrin and metallopeptidase domain 8,  [NM_007403] ND 2,50 -3,7
Mmp12 matrix metallopeptidase 12, [NM_008605] ND 2,39 ND
Mmp8 matrix metallopeptidase 8, [NM_008611] ND -2,74 ND
Adam19 disintegrin and metallopeptidase domain 19, [NM_009616] ND ND -2,1
Mmp13 matrix metallopeptidase 13, [NM_008607] ND ND -2,7
Adamts2 disintegrin-like and metallopeptidase 3,65 ND ND
with thrombospondin type 1 motif, 2 [NM_175643]
integrins
Itgax integrin alpha X, [NM_021334] 2,39 2,25 ND
Itga2b integrin alpha 2b, [NM_010575] -2,02 ND ND
Itgam integrin alpha M, [NM_008401] -2,11 ND -2,1
Itga4 integrin alpha 4, [NM_010576] -2,63 ND -2,3
Itgb7 integrin beta 7, [NM_013566] -3,76 ND -3,5
Itgae integrin, alpha E, epithelial-associated, [NM_008399] ND 3,88 -3,1
Itgb3 integrin beta 3, [AK135584] -3,64 ND -2,78
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Figure 10. Volcano plot representation of differentially regulated genes among lung dendritic cells, 
lung macrophages and monocytes. Gene expression profiles of (A) lung macrophages (MΦ) versus 
peripheral blood monocytes (PBMo), (B) lung dendritic cells (DC) versus PBMo, and (C) lung MΦ versus 
lung DC were plotted according to the log2 fold change (X axis) and log10 unadjusted p-value (Y axis). The 
genes for which the expression has been validated by qRT-PCR are highlighted. Data are representative of 
four hybridizations per group. 
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Figure 14. Validation of microarray-based expression pattern of metalloproteinase genes by qRT-
PCR. Peripheral blood monocytes (PBMo), lung macrophages (MΦ) and dendritic cells (DC) were sorted 
as shown in Fig. 7A and 8A. The mRNA expression was assessed by qRT-PCR analysis for 
metalloproteinases. Data represent 3-4 independent experiments per group. * indicates p<0.05, ** indicates 
p<0.01, *** indicates p<0.001. A non-detectable gene expression is indicated by n.d. (not detected). 
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Figure 15. Validation of microarray-based expression pattern of chemokine and interleukin genes by 
qRT-PCR. Peripheral blood monocytes (PBMo), lung macrophages (MΦ) and dendritic cells (DC) were 
sorted as shown in Fig. 7A and 8A. The mRNA expression was assessed by qRT-PCR analysis for 
chemokines and interleukins. Data represent 3-4 independent experiments per group. *indicates p<0.05, 
**indicates p<0.01,*** indicates p<0.001 
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Figure 16. Validation of microarray-based expression pattern of integrin genes by qRT-PCR. 
Peripheral blood monocytes (PBMo), lung macrophages (MΦ) and dendritic cells (DC) were sorted as 
shown in Fig. 6A and 7A. The mRNA expression was assessed by qRT-PCR analysis for integrins. Data 
represent 3-4 independent experiments per group. * indicates p<0.05, ** indicates p<0.01, *** indicates 
p<0.001 
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3.3 Isolation and gene expression profiling of subpopulations of 
peripheral blood monocytes and lung macrophages 
The microarray experiments described above were designed to compare the gene 
expression profiles of PBMo and their fully differentiated pulmonary progeny lung DC 
and lung MΦ on a genome-wide scale. This approach, however, does not detect potential 
differences in gene expression between intermediate differentiation stages or distinct 
subpopulations of circulating or lung tissue mononuclear phagocytes, which have been 
ascribed different migratory and differentiation properties. Thus, the two dominant 
subpopulations of PBMo, the “inflammatory” (GR-1pos) and the “resident” (GR-1neg) 
subsets, have been attributed with different biological functions, including recruitment 
under inflammatory versus steady-state conditions, and differentiation into functionally 
different DC and MΦ populations [7, 81]. To further identify possible differences in the 
expression profiles of the selected genes, GR-1high and GR-1low PBMo were sorted for 
qRT-PCR analysis based on the expression of CD11b, CD115 and GR-1, as depicted in 
(Fig. 17A). Like PBMo, lung MΦ can be divided into two major populations according to 
their anatomical location, the parenchymal or interstitial (iMΦ), and the resident alveolar 
macrophages (rAMΦ). Whether these populations represent functionally different 
subpopulations has long been a matter of debate. Recent reports, however, indicate a 
functional and developmental difference, with the iMΦ being proposed as precursor cells 
for rAMΦ [17]. For the separation of rAMΦ, BALF was obtained from mouse lungs, and 
rAMΦ were flow-sorted from the lavage by gating the high FL1 autofluorescent, 
CD11cpos cell population (Fig. 17B). By lavaging it is possible to remove > 90% of the 
rAMΦ from mouse lungs [82]. In the current experiments, the lavage procedure depleted 
rAMΦ efficiently from the lungs, thus enriching the iMΦ subset, following an approach 
used by Landsman et al. [17, 18]. No additional rAMΦ could be obtained by serial 
lavage, indicating an efficient lavaging procedure. Enriched interstitial iMΦ and DC were 
then isolated from homogenates obtained from lavaged lungs (Fig. 17C) using the sorting 
strategy described above (Fig. 8A). 
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Figure 17 Isolation strategy of subpopulations of peripheral blood monocytes and lung macrophages. 
(A) Peripheral blood monocytes (PBMo) were flow-sorted from peripheral blood leukocytes by gating on 
the low SSC/CD11bpos/CD115pos population, as shown in Fig. 1. Additional gates were set on the GR-1-
positive (PBMo GR-1high) and GR-1-negative (PBMo GR-1low) subsets of PBMo. (B) Resident alveolar 
macrophages (rAM) were flow-sorted from BAL fluid by gating on the high FSC/high SSC/CD11cpos/high 
autofluorescent cell population. (C) After BAL, lungs were removed, and CD11cpos cells were isolated from 
lung homogenates using magnetic beads as described. Subsequently, CD11cpos cells from lung homogenates 
were flow-sorted for the low autofluorescent population representing lung DC and the high autofluorescent 
population representing MΦ as described. Note that the majority of rAM had been removed from lungs by 
lavage prior to homogenization, and that the flow-sorted MΦ mainly represent iMΦ. Displayed data are 
representative of 5-6 independent sorting experiments per group. 
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Figure 18. Relative mRNA expression of metalloproteinase genes from lung dendritic cells and 
subpopulations of lung macrophages and peripheral blood monocytes by qRT-PCR. Lung interstitial 
macrophages (iMΦ) and resident alveolar macrophages (rAM) as well as lung dendritic cells (DC) were 
sorted as shown in Fig. 17, and mRNA expression was assessed by qRT-PCR analysis. Data represent 3-4 
independent experiments per group. * indicates p<0.05, ** indicates p<0.01, *** indicates p<0.001.  
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Figure 19. Relative mRNA expression of chemokine and interleukin genes from lung dendritic cells 
and subpopulations of lung macrophages and peripheral blood monocytes by qRT-PCR. GR-1high 
(Mo+) and GR-1low (Mo-) peripheral blood monocytes (PBMo), lung interstitial macrophages (iMΦ) and 
resident alveolar macrophages (rAM) as well as lung dendritic cells (DC) were sorted as shown in Fig. 17, 
and mRNA expression was assessed by qRT-PCR analysis. Data represent 3-4 independent experiments 
per group. * indicates p<0.05, ** indicates p<0.01, *** indicates p<0.001 
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Figure 20. Relative mRNA expression of integrin genes from lung dendritic cells and subpopulations 
of lung macrophages and peripheral blood monocytes by qRT-PCR. GR-1high (Mo+) and GR-1low (Mo-) 
peripheral blood monocytes (PBMo), lung interstitial macrophages (iMΦ) and resident alveolar 
macrophages (rAM) as well as lung dendritic cells (DC) were sorted as shown in Fig. 17, and mRNA 
expression was assessed by qRT-PCR analysis. Data represent 3-4 independent experiments per 
group.* indicates p<0.05, ** indicates p<0.01, *** indicates p<0.001.  
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The differential expression of selected genes was further evaluated in the GR-1high and 
GR-1low subsets of PBMo, iMΦ and rAMΦ, as well as in lung DC, by qRT-PCR (Fig. 18, 
19, 20). Differences in the mRNA expression of all selected genes were statistically 
significant, and demonstrated the same expression trends as the results obtained by 
microarray experiments (Fig. 18, 19, 20). Further information was obtained with respect 
to differences in gene expression between subpopulations of PBMo and lung MΦ. iMΦ 
and rAMΦ exhibited significantly different gene expression in 14 out of 17 analyzed 
genes and GR-1high and GR-1low subsets of PBMo differed in 5 out of 10 analyzed genes, 
suggesting a functional and/or developmental difference. 
Expression levels of MMPs in PBMo subpopulation were very low or not detectable in 
qRT-PCR experiments, except for Mmp14, Mmp19 and Adam19 (Fig. 18). Expression of 
Mmp19 and Adamts2 did not differ between iMΦ and rAMΦ, but both genes exhibited 
elevated expression compared to DC. All other MMPs examined exhibited higher 
expression levels in DC in comparison to iMΦ and rAMΦ. The GR-1high and GR-1low 
PBMo subsets did not differ in integrin expression, but significant differences were 
observed in all other genes analyzed, especially with respect to chemokine and 
chemokine receptor expression, confirming and expanding previous reports. The 
expression profile of lung DC was essentially similar to the expression profiles of PBMo 
subpopulations, while subpopulations of lung MΦ significantly differed. 
 
3.4 Confirmation of selected integrin expression by flow cytometry on 
subsets of peripheral blood monocytes, lung macrophages, and lung 
dendritic cells 
 
To further assess whether transcript levels demonstrated the same protein expression 
pattern, the integrins examined by qRT-PCR on mononuclear phagocyte populations 
(Fig. 20) were also assessed for cell surface expression by quantitative flow cytometry 
(Fig. 21). The cell surface expression levels of the respective integrin molecules 
demonstrated the same expression trends as the observed mRNA levels in the 
mononuclear phagocyte subsets analyzed. In particular, iMΦ and rAMΦ lose expression 
of most selected integrins, except integrin αM, which was partially expressed by iMΦ, 
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but was not present in rAMΦ. In contrast, integrin β1, β2 and β3 expression remains high 
in lung DC. Integrin αE was expressed exclusively on a lung DC subset, and its 
expression pattern was identical to the expression of integrin β7, suggesting co-
expression of integrins αE and β7 on subpopulation of DC, which has previously been 
described [83]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21. Differentially regulated integrins from lung dendritic cells and supopulations of lung 
macrophages and peripheral blood monocytes assessed by flow cytometry. GR-1-positive peripheral 
blood monocytes (PBMo) GR-1high and GR-1-negative (PBMo GR-1low) subsets of PBMo, lung interstitial 
(iMΦ) and alveolar (rAM) macrophages, and lung dendritic cells (DC) were isolated as described and 
analyzed by flow cytometry for the expression of the indicated integrins. Gates on the respective cell 
populations were set as illustrated in Fig. 17. Open histograms indicate specific fluorescence of the 
indicated antigen; shaded histograms represent control stained cells. Displayed data are representative of 
three independent experiments. 
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3.5 Serotonin receptor expression in the lung 
 
3.5.1 Alveolar macrophages express the 5-HT2C receptor 
 
The microarray data suggested the expression of 5-HT2C receptor on lung MΦ. This gene 
was significantly upregulated, based on microarray experiment data, on MΦ in 
comparison with DC and PBMo. This finding was validated by qPCR. To have an 
impression of how the expression of this receptor is distributed among lung cells a qPCR 
was performed including alveolar epithelial cells (AEC) (Fig. 22). The expression of 
serotonin 5-HT2C receptor was not detected in AEC and was significantly upregulated in 
lung MΦ in comparison with lung DC. Additionally there was a difference in the 
expression of 5-HT 2C receptor between iMΦ and rAMΦ; with highest expression levels 
detected in iMΦ. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22. The expression of 5-HT2C receptor in lung cells examined by qRT-PCR. PBMo (peripheral 
blood monocytes), lung MΦ (macrophages), DC (dendritic cells) and AEC (alveolar epithelial cells) 
mRNA expression was assessed by qRT-PCR analysis for 5-HT2C. Data are presented as mean ± SD of 4 
independent experiments per group. All differences between gene expressions were statistically significant 
with p < 0.05 except where indicated by n.s. (not significant). A non-detectable gene expression is 
indicated by n.d. (not detected). 
 
3.5.2 The serotonin receptors 5-HT2A/2B are expressed by alveolar epithelial cells 
 
Amongst type 2 serotonin receptors apart from the 2C receptor there are two more 
members: 2A and 2B receptors. The mRNA expression of all type 2 serotonin receptor 
was examined by qPCR in lung cells (Fig. 23, 24). The serotonin receptors 5-HT2A and 5-
HT2B were most upregulated on AEC and to a lesser extent on lung DC. Lung MΦ had 
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the lowest expression of compared cell types, but still detectable. To characterize the 
expression of 5-HT receptors in MΦ subsets and AEC, high purity cell sorting and qRT-
PCR was employed, as recently described [84]. Alveolar and interstitial MΦ express high 
levels of mRNA coding for 5-HT2C and lower quantities of 5-HT2A and 5-HT2B mRNAs. 
The serotonin receptors 5-HT2A and 5-HT2B are expressed by AEC, which do not express 
detectable mRNA levels of 5-HT2C (Fig. 22).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. The expression of 5-HT2A receptor in lung cells examined by qRT-PCR. PBMo (peripheral 
blood monocytes), lung MΦ (macrophages), DC (dendritic cells) and AEC (alveolar epithelial cells) 
mRNA expression was assessed by qRT-PCR analysis for 5-HT2A. Data are presented as mean ± SD of 4 
independent experiments per group. All differences between gene expressions were statistically significant 
with p < 0.05 except where indicated by n.s. (not significant).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24. The expression of 5-HT2B receptor in lung cells examined by qRT-PCR. PBMo (peripheral 
blood monocytes), lung MΦ (macrophages), DC (dendritic cells) and AEC (alveolar epithelial cells) 
mRNA expression was assessed by qRT-PCR analysis for 5-HT2B. Data are presented as mean ± SD of 4 
independent experiments per group. All differences between gene expressions were statistically significant 
with p < 0.05 except where indicated by n.s. (not significant).  
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3.6 Serotonin action in the lung 
 
3.6.1 Serotonin increase CCL2 production by alveolar macrophages acting through 
the 5-HT2C receptor  
 
To test whether serotonin acts on rAMΦ and if 5-HT2C has any function in rAMΦ the 
production of one of the most common macrophage chemokines (CCL2) was examined 
(Fig. 25). Indeed, stimulation with serotonin increased CCL2 release, and this effect was 
completely abrogated in ko animals which lacked 5-HT2C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25. CCL2 protein production is increased in resident alveolar macrophages upon serotonin 
stimulation. Resident alveolar macrophages were stimulated with 10-5 M serotonin (5-HT) and cultured for 
24 h. CCL2 was quantified by ELISA. Data represent 3-4 independent experiments per group. * indicates 
p<0.05. KO-knockout animals lacking 5-HT2C, WT-wild type animals 
 
There was a significant increase in levels of CCL2 in culture supernatants from rAMΦ 
cultured under basal conditions, compared to rAMΦ treated with 5-HT. The expression 
levels of CCL2 did not change upon 5-HT stimulation when experiments were performed 
on rAMΦ isolated from 5-HT2C deficient animals, indicating an involvement of that 
receptor in the CCL2 secretion (Fig. 25). To investigate whether CCL2 production 
reflected a release of stored intracellular chemokine into the supernatant or if it is 
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accompany by transcriptional regulation qPCR was performed. After 4 h there was a 
significant increase in CCL2 mRNA expression in rAMΦ stimulated with 5-HT, while no 
difference in CCL2 mRNA expression was observed in 5-HT2C deficient animals, once 
more proving a role of this receptor on rAMΦ response to 5-HT (Fig. 26). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. CCL2 mRNA production is increased in alveolar macrophages upon serotonin 
stimulation. Resident alveolar macrophages were stimulated with 10-5 M serotonin (5-HT) and cultured for 
4 h. The CCL2 mRNA was measured quantified by qPCR. Data represent 3-4 independent experiments per 
group. * indicates p<0.05 KO-knockout animals lacking 5-HT2C, WT-wild type animals  
 
 
3.6.2 Microarray analysis reveal transcriptional changes in alveolar macrophages 
stimulated with serotonin acting exclusively through the 5-HT2C receptor 
 
To assess how 5-HT can change the transcriptional profile of rAMΦ, whole mouse 
genome microarray was used to address this question. Freshly isolated rAMΦ were 
stimulated with 5-HT and after 4 h, cells were collected and RNA was isolated, 
transcribed to cDNA and hybridized on the array. To understand if the action of 5-HT 
was mediated by the 5-HT2C receptor; the same experiment setup was applied to mice 
lacking 5-HT2C.  
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There were 53 genes regulated in wild type rAMΦ stimulated with 5-HT and non in mice 
lacking 5-HT2C (Fig. 27). This clear result proved that 5-HT acts on rAMΦ at the 
transcriptional level, through the 5-HT2C receptor, and provided a list of interesting genes 
that are regulated upon 5-HT stimulation. 
Out of 53 genes regulated on the array, 39 were upregulated and 14 were downregulated. 
Many from upregulated genes were involved in cytokine activity (spp1), signal 
transduction involving G-protein coupled receptors (sphk1), biosynthetic processes (nt5e) 
or cell differentiation (csf1). Downregulated genes such as (ptges) are involved in anti-
inflammatory response, ECM organization (tgfbi) or exhibit peptidase activity (htra1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27. Volcano plots representing genes regulated in alveolar macrophages upon serotonin 
stimulation. Resident alveolar macrophages were isolated from 5-HT2C deficient (KO) (A) and wild type 
(WT) (B) animals and treated with 10-5 M serotonin (5-HT) for 4 h. Some differentially regulated, 
arbitrarily chosen genes were marked. 
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3.6.3 Validation of candidate genes by real time quantitative PCR  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28. Validation of spp1, nt5e and myo1d by qRT-PCR. Resident alveolar macrophages were 
isolated from 5-HT2C deficient (KO) (A) and wild type (WT) (B) animals and treated with 10-5 M serotonin 
(5-HT) for 4 h. The mRNA of selected genes was measured quantified by qPCR. Data represents 3-4 
independent experiments per group. * indicates p<0.05  
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To validate the microarray results three genes (spp1, nt5e, myo1d) were chosen and their 
mRNA expression was assessed by qPCR. The expression profile was consistent with 
microarray results. There was an increase in mRNA expression of the genes listed above 
when wild type rAMΦ stimulated with 5-HT were compared with unstimulated control, 
and no difference was observed in the expression of rAMΦ from 5-HT2C deficient 
animals stimulated with 5-HT compared with unstimulated control (Fig. 28). 
 
 
3.6.4 Serotonin increase the production of MIP-2 in alveolar epithelial cells  
 
To examine if 5-HT had any effect on AEC primary AEC on the third day of culture were 
stimulated with 5-HT. An increase in MIP-2 production was observed after 24 h, as well 
as after 48 h of culture. Since AEC do not express 5-HT2C serotonin receptor MIP-2 
increase in expression is mediated by other type of receptor(s). 
 
 
 
 
 
Figure 29.  MIP-2 production is increased in alveolar epithelial cells upon serotonin stimulation. 
Alveolar epithelial cells (AEC) were stimulated with 10-5 M and 10-4 M serotonin (5-HT) and cultured for 
24 h and 48 h. MIP-2 concentration was quantified by ELISA. Data represent 3-4 independent experiments 
per group. All differences between MIP-2 productions were statistically significant with p < 0.05 except 
where indicated by n.s. (not significant).  
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3.6.5 TNF-α production in alveolar macrophages is not modulated by presence of 
serotonin 
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Figure 30. TNF-α protein level in bronchoalveolar lavage fluid is not modulated upon serotonin 
stimulation. Mice were intratracheally stimulated with 10-5 M serotonin (5-HT) in presence or absence of 
LPS. Mice were sacrificed after 6 h and bronchoalveolar lavage fluid was quantified by ELISA for the 
presence of TNF-α. Data represents 9 independent experiments per group. All differences between TNF-α 
production were statistically significant with p < 0.05 except where indicated by n.s. (not significant). 
 
 
One of the first responses of rAMΦ to bacterial assault is increased TNF-α production. 
To assess the role of 5-HT in one of the first reactions of rAMΦ in vivo we treated mice 
with LPS in presence or absence of 5-HT and TNF-α production from BALF was 
assessed. After 6 h post LPS stimulation no significant difference in TNF-α level in 
BALF was observed between mice treated with or without 5-HT (Fig 30). Additionally, 
5-HT alone did not influence TNF-α production. A similar experiment was conducted in 
vitro (Fig. 31). Freshly isolated rAMΦ were stimulated with LPS alone, or together with 
5-HT, and TNF-α production was assessed after 6 h. Here, again no significant difference 
was observed between rAMΦ treated with LPS alone or together with 5-HT, suggesting 
that 5-HT does not play a role in rAMΦ TNF-α production upon LPS stimulation. 
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Figure 31. TNF-α protein production in vitro in alveolar macrophages is not modulated upon 
serotonin stimulation. Resident alveolar macrophages were stimulated with 10-5 M serotonin (5-HT) with 
presence or absence of LPS and cultured for 6 h. TNF-α production was quantified by ELISA. Data 
represents 6 independent experiments per group. All differences between TNF-α production were 
statistically significant with p < 0.05 except where indicated by n.s. (not significant).  
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3.7 Gramd3 as a potential cell surface marker for lung dendritic cells 
 
Based on the present knowledge there is no single, specific marker that could 
discriminate between lung MΦ and DC. The need for such a marker comes from the fact 
that the isolation procedure, as well as analysis by flow cytometry of MΦ and DC would 
be much easier. These two cell types are visibly different assessed even by light 
microscopy, so there is a strong indication that such a marker, specific for just one type 
might exist.    
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Figure 32. The expression of gramd3 in peripheral blood monocytes, lung macrophages and lung 
dendritic cells examined by qRT-PCR. Peripheral blood monocytes (PBMo), lung macrophages (MΦ) 
and dendritic cells (DC) mRNA expressions were assessed by qRT-PCR analysis for Gramd3. Data are 
presented as mean ± SD of 4 independent experiments per group. All differences between gene expressions 
were statistically significant with p < 0.05  
 
 
Microarray data provided a list of known and unknown genes that code for proteins that 
are transmembrane and could be evaluated as markers. From the discovery point of view 
it would be more interesting to investigate an unknown gene and not only prove it as a 
DC marker but also assign it a biological function. 
Microarray results were screened for unknown genes that were significantly upregulated 
on DC in comparison to PBMo and MΦ and additionally had transmembrane domains. 
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Gramd3 (NM_026240, GRAM containing domain 3) was the only gene from the selected 
genes that was validated by qPCR (Fig. 32). The GRAM domain is found in 
glucosyltransferases [85], myotubularins [86] and other putative membrane-associated 
proteins associated with membrane traffic and pathogenesis and signal transduction. 
At this moment the next step in establishing Gramd3 as a new DC marker would be to 
raise antibodies against the protein produced by this gene and stain the lung sections to 
examine if Gramd3 is really specific for lung DC. 
. 
3.8 Expression of proteases on lung dendritic cells 
 
 
 
 
Figure 33. Protease expression is increased in lung dendritic cells in comparison with alveolar 
macrophages. Resident alveolar macrophages (rAM) and lung dendritic cells (DC) were flow sorted and 
their expression of proteases was measured by western blot analysis. Experiment was done in triplicate and 
figure shows a representative blot. 
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There were three groups of gene clusters in the microarray analysis that were involved in 
cell trafficking, namely MMPs, integrins and chemokines. A decision to continue with 
just one group had to be made, for practical reasons. Since chemokine and integrin 
involvement in the immune cell recruitment to the lung is well established, the research 
interest was narrowed to the expression of MMPs on lung DC. Dendritic cells in the 
lungs exhibited the highest expression of MMPs from cells compared in the microarray 
study.  
The expression pattern of MMPs in rAMΦ and DC obtained from the microarray 
experiment was validated at the protein level by western blot analysis (Fig. 33). The 
expressions of all compared proteases were upregulated in DC in comparison with 
rAMΦ. The Mmp14 and GzmB expressions were slightly upregulated, while other 
proteases were strongly upregulated. Interestingly, Mmp12 was hardly detectable in 
rAMΦ. 
 
3.9 Granzyme B is active in lung dendritic cells 
 
The decision to continue research with granzymes was based on the fact that knockout 
animals were available, fertile, exhibited distinct phenotype and that difference in GzmB 
expression between rAMΦ and DC was one of the most significant of all compared 
proteases. Western blots could not answer the question if granzyme is active and 
functional in DC. To establish whether this was the case, flow sorted DC were cultured 
for 24 h in presence or absence of LPS. Subsequently, supernatants and cell lysates were 
examined for granzyme activity (Fig. 34). Only in cell lysates, and not in supernatant, 
granzyme activity was observed. The LPS stimulation did not modulate granzyme 
activity.  
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Figure 34. Granzyme B activity is increased in lung dendritic cells in comparison with alveolar 
macrophages assessed by a fluorescent substrate activity assay. Lung macrophages (AM) and dendritic 
cells (DC) were flow sorted and lysed. Lysates were incubated with granzyme B substrate for 30 s. 
Fluorescence was measured in a fluorometer at excitation wavelength 400   nm and at emission wavelength 
505 nm. Data represent 3-4 independent experiments per group. * indicates p<0.05  
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4. Discussion 
 
4.1 Microarray analysis as a tool for studying the mononuclear 
phagocyte system in the lung 
The constant maintenance of both DC and MΦ cell pools in the lung is essential for 
effective immune surveillance in pulmonary tissue. Recent reports highlight the role of 
PBMo that emigrate into the lung and differentiate into both lung DC and MΦ, thereby 
serving as a constant supply for the renewal of the lung DC and MΦ pool [18]. While 
many studies have investigated monocyte recruitment under inflammatory conditions, 
little is known about the pathways mediating monocyte trafficking and differentiation in 
lung tissue under non-inflammatory conditions [81, 87, 88]. Since PBMo are believed to 
be precursors for lung MΦ and DC, a global gene expression profiling approach was 
chosen to reveal crucial differences between these cell types, to better understand their 
relation to one another, and to identify gene clusters relevant for the migration and 
differentiation process that takes place under steady-state conditions. Previous microarray 
studies investigating the relation, differentiation and/or maturation of monocytes, MΦ 
and DC have been mainly conducted in vitro, using both murine and human cells [89-91]. 
A study comparing primary human MΦ versus MΦ differentiated in vitro from PBMo 
has demonstrated significant differences in gene expression profiles [92], indicating the 
necessity of carefully elaborating the differences and similarities between in vivo and in 
vitro differentiation. A recent publication from our group compared gene expression 
profiles of murine mononuclear phagocytes recruited to the alveolar space under 
noninflammatory and inflammatory conditions using 1 K nylon arrays [93]. The present 
study was undertaken as the first in vivo investigation using cell specific whole genome 
expression profiling of key players in lung immunity, namely lung MΦ and lung DC and 
their circulating precursors PBMo, to define the gene expression differences between 
these three cell populations under non-inflammatory conditions in mice. By this, it could 
be demonstrated that approximately 5–10% of the transcriptome are differentially 
regulated between these three cell populations which are closely related with respect to 
origin, destination and function. Whether these expression differences represent 
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preformed, lineage-specific differentiation programs or are rather due to the interaction of 
migrating PBMo and specific micro-environmental factors of the lung must be addressed 
in detail in subsequent studies. 
4.1.1 Differentially regulated genes between lung macrophages and lung dendritic 
cells are essential for cell migration 
Lung DC and MΦ play diverse functional roles in the innate immunity, and their 
localization to different compartments of the lung suggests different migration properties 
of these cell types. Under steady-state conditions, DC largely reside in the interstitial 
compartment, with only minor parts located in the alveolar space, and ultimately they 
emigrate to the thoracic lymph nodes to present antigen to T cells. Conversely, MΦ 
readily pass through the epithelial barrier and enter the alveolar airspaces, which very 
likely represents a terminal destination. Hypothesizing that DC and MΦ residing in 
different environments most likely require different migration and tissue invasion 
capacities, differentially expressed genes were grouped into trafficking related clusters 
such as integrins, MMPs, chemokine and chemokine receptors, and interleukins and 
interleukin receptors. Integrins are key mediators of cell-cell interactions, and given their 
different tissue localization, DC and MΦ most likely have to interact with different cell 
types or the ECM. Indeed, the lack of integrin gene expression in rAMΦ suggest that 
these cells require less integrin-mediated cell-cell communication than both subsets of 
PBMo and lung DC, which is consistent with the view of rAMΦ being confined to the 
alveolar space, rather than possessing extensive migratory properties. Members of the 
MMP family can cleave components of the ECM, thereby facilitating cell migration [94]. 
Furthermore, MMPs can modulate the activity of chemokines [95], cytokines [96], and 
selectins [97]. Chemokines themselves also regulate MMPs and integrin avidity [98-100]. 
The different biological functions of DC and MΦ would imply that these cell types have 
different interactions with their direct environment, suggesting the differential expression 
of genes that regulate cell interaction with the ECM, and responses to chemokines and 
cytokines. Our data show that DC and MΦ express different clusters of MMP as well as 
cytokine and chemokine receptor genes, indicating distinct patterns of migration 
properties. Another important aspect of this study is the detailed delineation of the 
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expression pattern of chemokines and their receptors in PBMo, lung MΦ and lung DC 
under non-inflammatory conditions. The microarray and qRT-PCR analyses demonstrate 
that all three cell populations express a variety of both chemokines and receptors. The 
qRT-PCR analysis of the mRNA levels in iMΦ and rAMΦ, however, indicates a more 
active participation in chemokine production by the iMΦ than by the rAMΦ population. 
4.1.2 Differentially regulated integrins: validation of microarray results at the 
protein level 
The gene expression patterns obtained from our study suggest that lung DC are 
phenotypically more related to PBMo than lung tissue MΦ. When further comparing the 
transcriptional regulation of selected genes in the lung macrophage subpopulations by 
qPCR, the transcripts of CCR2, CCL2, CCR7 and CD61 all highly expressed in PBMo 
were found to be less downregulated in iMΦ compared to rAMΦ. This finding supports a 
recent report by Landsman et al., suggesting that iMΦ are an intermediate stage in the 
differentiation process to rAMΦ [17]. An important issue when interpreting DNA 
microarray data is whether mRNA expression levels demonstrates the same expression 
trends as the expression of the encoded proteins. Notably, the transcriptional expression 
patterns of selected integrins obtained by DNA array and qRT-PCR were found to 
demonstrate the same expression trend as the expression levels of the respective proteins 
on the cell surface as detected by flow cytometry. 
4.2 Serotonin acts on alveolar macrophages through the 5-HT2C 
receptor 
 
4.2.1 Expression of serotonin receptors in the lung 
 
In this study, the first evidence for functional expression of 5-HT2C receptors on mouse 
lung MΦ is provided. In freshly isolated rAMΦ, 5-HT rapidly stimulates intracellular 
calcium elevation and leads to increased production of the monocyte chemoatractant 
CCL2, as well as changes in the transcriptional profile based on an unbiased microarray 
study. 
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While many studies have investigated effects of 5-HT on cytokine production in various 
immune cells, little is know about the action of 5-HT on lung MΦ. Acute effects of 5-HT 
on rAMΦ have not been investigated so far. Previous studies have pointed to the 
importance of 5-HT2 receptors in a development of bleomycin-induced pulmonary 
fibrosis in mice [57] and monocrotaline-induced pulmonary hypertension in rats [58]. 
The first evidence of 5-HT2C expression on MΦ was suggested by Zasłona et al. [84] 
based on microarray study. In the lung 5-HT2 receptors are differentially expressed by 
rAMΦ and AEC. This finding supports a recent work by Fabre et al. which shows the 
expression of 5-HT2A and 5-HT2B on murine pneumocytes [57]. Interestingly, both 
alveolar and lung interstitial MΦs express high levels of 5-HT2C mRNA, but they express 
lower quantities of other two 5-HT2A/B receptors. 
4.2.2 Alveolar macrophages increase CCL2 production upon serotonin stimulation 
 
To get general insights into physiological responses of rAMΦ upon 5-HT stimulation, 
secretion of inflammatory mediators by rAMΦ was measured with the use of a dot-blot 
based assay. Indeed, changes in the production of inflammatory mediators were observed. 
Mainly CCL2, but also CCL5, TNF-α, KC and MIP-2 production was increased by 5-HT 
stimulation. Increased CCL2 production in 5-HT stimulated rAMΦ was validated by 
ELISA. Importantly, KO cells do not increase CCL2 in response to 5-HT, proving 
involvement of the 5-HT2C in those responses. In addition, CCL2 mRNA was increased 
upon 5-HT stimulation, and again this effect was 5-HT2C-dependent. 
The CCL2 production is induced by variety of cells upon infection and is responsible for 
the migration of immune cells to the site of infection [9] (Fig. 35). The CCL2 is a 
chemokine that drives monocytes recruitment to the lung under inflammatory conditions 
[101]. This phenomenon was confirmed in bacterial [102] and viral [103] models of lung 
inflammation, however in both settings AEC were responsible for CCL2 increase. 
According to the data generated in our group rAMΦ do not play a role in monocyte 
recruitment process in non-inflamed lung, e.g. elicited by CCL2 installation. However in 
a combined LPS/CCL2 challenge depletion of rAMΦ decreased alveolar neutrophil and 
monocyte recruitment [88]. Mouse rAMΦ carry CCR2 receptors, indicating potential 
binding of CCL2 [88] and are also known to produce CCL2 in response to different 
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stimuli, however in lower quantities than AEC. It has been shown that CCL2 production 
in rat NR8383 Macrophage cell line can be increased by ATP, and the release from 
induced cells can be attenuated after chelating intracellular Ca2+ with BAPTA [104]. 
Since CCL2 is stored in cytosolic granules [105], it is possible, that 5-HT promote release 
of stored CCL2 via exocytosis which is a Ca2+- and G-protein-dependent process [106]. 
To summarize one can comment that MΦ are not the main producers of CCL2 in the 
lung, but increase of CCL2 release by rAMΦ upon 5-HT stimulation may play a role in 
microenvironment, e.g. by promoting crosstalk between MΦ and AEC.  
Since 5-HT levels are elevated in inflamed tissues [44] it is possible that MΦ and AEC 
have contact and react to 5-HT under local inflammatory conditions (Fig. 36, 37). It is 
also likely that AEC and MΦ reaction to 5-HT is quite different since 5-HT2C is just 
present on AM. The serotonin 5-HT2A/B receptors, based on our study, are not responsible 
for CCL2 production in MΦ. Moreover, AEC which express 5-HT2A/B do not increase 
CCL2 production upon 5-HT stimulation (data not shown). It can be speculated that upon 
contact with 5-HT, CCL2 production starts in small levels in MΦ, and that facilitates 
AEC activation by CCR2-dependent mechanism [107]. 
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Figure 35. Models of CCL2 mediated monocyte recruitment. Adapted from Serbina et al .2008 [9]. 
During infection MCP-1 (CCL2) is produced and secreted by infected or cytokine stimulate non-infected 
cells. (a) In the first model secreted MCP-1 establishes a gradient across the distance from infection site 
and attracts monocytes to the infection sites. (b) In an alternative model MCP-1 gradient is established not 
by distance from chemokine production site but rather by chemokine binding with specific 
glycosaminoglycans (GAGs).  
 
 
4.2.3 Serotonin changes the transcriptional profile of alveolar macrophages 
 
To better understand transcriptional changes in rAMΦ upon 5-HT stimulation, a 
microarray analysis was performed on whole mouse genome. Experiments were 
performed on rAMΦ isolated from wild type and 5-HT2C-deficient animals. Differentially 
expressed genes were present just in the first group, indicating that 5-HT acts on rAMΦ 
(CCL2) 
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exclusively through 5-HT2C. Differentially regulated genes on rAMΦ cover a broad 
spectrum of functions important for rAMΦ biology. From upregulated genes on rAMΦ 
upon 5-HT stimulation osteopontin (spp1) is known to be involved in interstitial lung 
diseases [108] and airway remodeling [109]. Increased osteopontin production in the 
lungs is associated with airway collagen deposition in experimental model of allergen 
induced airway remodeling [110]. If transcriptional changes in osteopontin in rAMΦ 
translate to protein expression, it can be speculated that 5-HT can play a role in local lung 
remodeling by acting on rAMΦ through 5-HT2C, as it was suggested by Fabre et al. for 5-
HT2A/B on AEC [57]. At the same time nt5e, which was upregulated on rAMΦ in our 
study and which protein product converts AMP to adenosine is involved in the protection 
against ventilator induced lung injury assessed by decreased protein content in BAL, 
decreased water in lung [111] and decreased neutrophil influx in LPS-treated lungs [112]. 
Additionally nt5e was proved to be important in attenuating pulmonary inflammation and 
fibrosis in bleomycin induced injury model, where in nt5e-deficient animals osteopontin 
and other profibrotic mediators were increased [113]. Further study has to be conducted 
to confirm if 5-HT stimulated rAMΦ increase osteopontin and nt5e on protein level and 
an animal model has to be chosen to validate a role of 5-HT and complex interplay of 
listed above genes in lung pathology. 
In conclusion, 5-HT was established as a novel modulator of rAMΦ function. In this 
study, the first evidence for 5-HT2C exclusive role in rAMΦ activation is provided, 
assessed by transcriptional and functional changes.   
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Figure 36. Serotonin under steady-state conditions in the lung. Under steady state conditions epithelial 
cells (in gray) and alveolar macrophages (AM) in blue do not have contact with high levels of serotonin   
(5-HT) 
 
 
Figure 37. Serotonin in lung inflammation. During lung inflammation there is a recruitment of 
neutrophils (violet) and monocytes (yellow) from the blood together with platelets (red) that by aggregation 
in the lung release serotonin that acts on alveolar macrophages (AM) in blue through 5-HT2C and epithelial 
cells (gray) through  5-HT2A/B. AM start to produce MCP-1 (CCL2), while AEC produce MIP-2.    
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4.3 Expression of proteases in lung dendritic cells 
 
4.3.1 Differential expression of MMPs among peripheral blood monocytes, lung 
dendritic cells and macrophages 
It has previously been shown that Mmp2 and Mmp9 are critically required by DC for 
recruitment to the airways in a murine model of asthma [114] and for the migration of 
DC from the skin to the lymph nodes [115]. While a difference in gene expression of 
Mmp2 and Mmp9 between lung DC and lung AM could not be demonstrated by 
microarray, five members of the MMP family, Adam19, Adam23, Mmp12, Mmp13 and 
Mmp14 were identified, which were dramatically upregulated in lung DC versus MΦ; 
while Mmp19 was upregulated in both iMΦ and rAMΦ, compared to DC. In contrast, 
expression of MMPs except Mmp8, Mmp19 and Adam19 in PBMo was low or not 
detectable, indicating that the transcriptional upregulation of proteases is an important 
and immediate step in the differentiation process after PBMo emigration from the blood 
into the lung. However, the exact role played by these differentially expressed members 
of the MMP family in cell migration, phagocytosis and antigen processing has to be 
further delineated. Similarly, the mechanisms by which MMPs regulate the function of 
chemokines, cytokines, and integrin expression, which influence DC and MΦ migration 
and activity, needs to be addressed in further studies.  
4.3.2 The expression of proteases assessed by western blot on lung dendritic cells 
 
Of the differentially expressed proteases, the majority was upregulated on lung DC. 
These data are novel, since to date most of investigations concerning expression of 
MMPs in the lung were restricted to MΦ.  
To validate the microarray results, western blot analysis was performed to examine 
whether expression of MMPs would also be altered at the protein level. Indeed, the 
expression of Adam19, Adam23, Mmp12, Mmp13, Mmp14 as well as GzmA and GzmB 
was upregulated in DC.  The largest difference in the expression levels between lung DC 
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and MΦ was observed for GzmB and Mmp13. It has to be kept in mind that the western 
blot analysis did not demonstrate the activity level of the examined proteases. 
 Both Mmp13 [116] and Mmp14 [117] play a pivotal role in cell cancer metastasis and 
invasion, so it can be speculated that the expression of these enzymes on DC may also be 
important in the migration process. It is difficult, however, to identify inhibitors that 
would specifically inhibit individual MMP members. In addition, protease substrate 
specificities overlap within the MMP family. These were the main concerns in the 
continuation of research with one of the members of MMP family expressed in lung DC. 
Additionally, the role of MMP in cell migration was often addressed in many 
publications, including studies in lung DC migration. Conversely, a role of granzymes in 
DC biology has not been addressed, and to the present day no study has been conducted 
to demonstrate the expression of granzymes in lung DC.    
4.3.3 Expression and role of granzymes in DC: future perspective 
The information that granzymes are expressed by DC is not completely new. Previous 
studies have shown that human pDC [67, 118], as well as monocyte derived human DC 
[119] express granzyme B. Different studies have focused on mouse and human myeloid 
DC, presenting data on mRNA level, for both granzyme A and B [120]. The suggested 
function for granzymes expressed in DC is cytotoxicity, but since perforin was not 
expressed, this was not the obvious role. Although an alternative pathway of granzyme-
mediated killing that does not involve perforin has been proposed [121], more probable is 
that DC express granzymes not for killing purpose, but rather for some extracellular 
functions. This idea is supported by the fact that there are non-cytotoxic cells expressing 
granzymes such as keratinocytes [122] or chondrocytes [123]. Additionally, in several 
diseases such as hypersensitivity pneumonitis [124], chronic allergic asthma [125], 
Plasmodium falciparum infection [126] or experimental endotoxemia  [127] elevated 
granzymes levels are observed. It is unlikely that elevated extracellular granzymes levels 
are due to cell killing processes, where release of granzymes to target cell is not precise. 
The extracellular role for granzymes may not just be ECM remodeling, as discussed 
previously, but could also be cell signaling mediated by cytokine production, which is 
supported by in vitro data [128, 129].  
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Lung DC, according to data presented here, express active granzyme B. To answer the 
question of what granzyme B does, we have to look back at dendritic cell biology. Lung 
DC, in comparison to MΦ, are much more mobile under steady state conditions. These 
cells constantly migrate from the blood to lungs seeking antigen to process and present to 
T-cells in lymph nodes (Fig. 38). Most probably, granzyme B is active in one or more 
processes during this journey. Granzyme B is either involved in DC migration through 
different compartments in the lung that require digestion of matrix proteins and basement 
membranes, or it plays a role in antigen presentation in processing and fragmentation of 
antigen for MHC class II loading. The best model to address this question would be an in 
vivo assay to examine DC migration, such as in ovalbumin coupled to fluorescin model 
and T-cell proliferation assay facilitated by carboxyfluorescein succinimidyl ester dyes. 
With the help of flow cytometry, different populations of lung DC could be examined. 
The pulmonary DC migration could be studied in the presence and absence of 
inflammation. The DC specific role of granzymes can be further studied using adoptive 
transfer of granzyme-deficient labeled lung DC into wild type recipient lungs to observe 
their migration and function.  
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Figure 38. Overview of lung dendritic cells migration. Adapted from Lambrecht and Hammad 2003 
[40]. Precursors of dendritic cells (DC) enter lungs from blood circulation. Immature DC search for 
antigen, and when antigen is taken up by DC, The DC mature and travel to the mediastinal lymph nodes, 
where DC select a specific T-cell from the polyclonal repertoire. If DC present antigen in a immunogenic 
manner, than within four days, this will lead to clonal expansion of antigen specific T-cell. This process is 
amplified in the presence of inflammation, increasing the possibility of pathogenic substances to be 
presented to naïve T-cells. 
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5. Summary 
 
Peripheral blood monocytes (PBMo) originate from the bone marrow, circulate in the 
blood, and emigrate into various organs where PBMo differentiate into tissue resident 
cellular phenotypes of the mononuclear phagocyte system (MPS), including macrophages 
(MΦ) and dendritic cells (DC). As in other organs, this emigration and differentiation 
process is essential to replenish the mononuclear phagocyte pool in the lung under both 
inflammatory and non-inflammatory steady-state conditions. While many studies have 
addressed inflammation-driven monocyte trafficking to the lung, the emigration and 
pulmonary differentiation of PBMo under non-inflammatory conditions is comparatively 
poorly understood.  
In order to assess the transcriptional profile of circulating and lung-resident MPS 
phenotypes, PBMo, lung MΦ and lung DC from naïve mice were flow-sorted to high 
purity, and cellular gene expression was compared by DNA microarray on a 
genome-wide scale. Differential regulation of selected genes was validated by 
quantitative polymerase chain reaction (qPCR) and at the protein level by flow 
cytometry.  
Differentially-expressed genes related to cell trafficking were selected and grouped into 
three clusters: (i) matrix metallopeptidases, (ii) chemokines/chemokine receptors, and 
(iii) integrins. Expression profiles of gene clusters were further examined at the mRNA 
and protein levels in subsets of circulating PBMo (GR1- versus GR1+) and lung MΦ 
(alveolar MΦ versus interstitial MΦ). These data identify differentially activated genetic 
programs in circulating monocytes and their lung descendents. Lung DC activate an 
extremely diverse set of genes, but largely preserve a mobile cell profile with high 
expression levels of integrins, chemokines and chemokine receptors. In contrast, 
interstitial and alveolar MΦ, downregulate gene expression of these traffic-relevant 
communication molecules, but strongly upregulate a distinct set of matrix 
metalloproteinases potentially involved in tissue invasion and remodeling.  
In addition, in this study, the first evidence for functional expression of 5-HT2C receptors 
on resident alveolar MΦ (rAMΦ) is provided. The inventory of 5-HT type 2 receptors in 
mouse lung MΦ and alveolar epithelial cells (AEC) was investigated by qPCR, which 
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revealed the expression of receptor subunits 5-HT2A and 5-HT2B on AEC and 5-HT2C on 
rAMΦ. Upon 5-HT stimulation, freshly isolated rAMΦ increased expression of CCL2 
mRNA as assessed by qPCR. Moreover, rAMΦ stimulated with 5-HT augmented 
production of CCL2 protein as indicated by dot-blot assay and enzyme-linked 
immunosorbent assay. In rAMΦ isolated from 5HT2C-deficient mice, CCL2 production at 
both the mRNA and protein level was not affected by 5-HT stimulation. The response of 
rAMΦ to 5-HT was also assessed at the whole mouse genome level, by microarray. 
Genes that were identified by microarray as being regulated were involved in cytokine 
activity, signal transduction, biosynthetic processes or cell differentiation. Taken 
together, these data demonstrate the presence of functional 5-HT2C receptors on rAMΦ 
and identify 5-HT as a novel modulator of rAMΦ function. 
Collectively, these data provide new insight into the changes of the genetic profiles of 
PBMo and their lung descendents, namely DC and MΦ under non-inflammatory, steady-
state conditions. Genes involved in cell trafficking expressed on DC were validated at the 
protein level, while expression of the 5-HT2C receptor in rAMΦ was investigated for its 
functionality. These findings will help to better understand the complex relations within 
the mononuclear phagocyte pool of the lung. 
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6. Zusammenfassung 
 
Periphere Blut Monozyten (PBMo) entstammen dem Knochenmark, sie zirkulieren im 
Blut und können in verschiedene Organe einwandern, wobei sich PBMo im Gewebe zu 
Zellen des Mononukleären Systems (MPS), wie Makrophagen (MΦ) und dendritische 
Zellen (DC) differenzieren. 
Wie in anderen Organen ist der Prozess des Auswanderns und Differenzierens von PBMo 
auch in der Lunge notwendig, um die Funktion des pulmonalen Monozyten-
Makrophagen Systems unter entzündlichen und nicht-entzündlichen Bedingungen zu 
gewährleisten. Während sich viele Studien der Entzündungs-gerichteten Monozyten-
Einwanderung in die Lunge gewidmet haben, ist über die Migration und pulmonale 
Weiterentwicklung von PBMo unter nicht-entzündlichen Bedingungen vergleichsweise 
wenig bekannt. 
Um das Transkriptionsprofil von zirkulierenden und in der Lunge residenten Zellen des 
MPS zu untersuchen, wurden PBMo, Lungen-MΦ und Lungen-DC von gesunden 
Mäusen mittels Durchflusszytometrie hochrein sortiert und ihre zelluläre Genexpression 
durch DNA-Microarray in einem Genom-weiten Maßstab verglichen. Unterschiedlich 
expremierte Gene wurden durch quantitative Polymerase-Ketten-Reaktion (qPCR) und 
auf Protein-Ebene mittels Durchflusszytometrie bestätigt. 
Differenziell regulierte Gene, die im Zusammenhang mit Zellmigration stehen, wurden 
ausgewählt und in drei Gruppen unterteilt: (i) Matrix Metalloproteinasen, (ii) Chemokine 
/ Chemokin-Rezeptoren, und (iii) Integrine. Expressionsprofile dieser Gen-Cluster 
wurden in Subpopulationen von zirkulierenden PBMo (GR1- versus GR1+) und Lungen 
MΦ (alveoläre MΦ versus interstitielle MΦ) auf mRNA und Proteine weiter untersucht. 
Diese Daten zeigten, dass in zirkulierenden Monozyten und ihren residenten 
Nachkommen in der Lunge unterschiedliche genetische Programme aktiviert werden. 
Pulmonale DC aktivieren eine äußerst heterogene Gruppe von Genen, erhalten jedoch 
weitgehend ein mobiles Zellprofil mit hoher Expression von Integrinen, Chemokinen und 
Chemokin-Rezeptoren. Im Gegensatz dazu regulieren interstitielle und alveoläre MΦ die 
Genexpression von Zellmigrations-relevanten Molekülen herunter, aktivieren hingegen 
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die Genexpression einer bestimmten Gruppe von Matrix Metalloproteinasen, die 
möglicherweise am Prozess des Gewebeumbaus und der Zellinvasion beteiligt sind.  
Desweiteren wurde in dieser Studie der erste Beleg für die funktionelle Expression von 5-
HT2C Rezeptoren auf residenten alveolären MΦ (rAMΦ) erbracht. Die 5-HT Typ 2 
Rezeptoren in MΦ und Alveolarepithelzellen (AEC) der Mauslunge wurden mittels 
qPCR untersucht, die die Expression von den Rezeptor-Untereinheiten 5-HT2A und 5-
HT2B auf AEC-und von 5-HT2C auf rAMΦ ergab. Frisch isolierte rAMΦ stimuliert mit 5-
HT, erhöhten die Expression von CCL2 mRNA und die Produktion des CCL2 Proteins, 
gezeigt durch qPCR, Dot-Blot und Enzyme Linked Immunosorbent Assay.  
In rAMΦ von 5HT2C-defizienten Mäusen wurde die CCL2 Produktion sowohl auf mRNA 
als auch auf Protein-Ebene durch 5-HT-Stimulation nicht gesteigert. Die transkriptionelle 
Reaktion von rAMΦ auf 5-HT wurde zusätzlich auf der Ebene des kompletten 
Mausgenoms mittels Microarray geprüft. Nach 5-HT Behandlung differenziell regulierte 
Gene, die mittels Microarray identifiziert wurden, sind an Zytokin-Aktivität, 
Signaltransduktion, Biosynthese-Prozessen und Zelldifferenzierung beteiligt. Diese Daten 
zeigen das Vorhandensein von funktionellen 5-HT2C Rezeptoren auf rAMΦ und 
identifizieren 5-HT als neuartigen Modulator der Funktion von rAMΦ.  
Zusammengenommen bieten diese Daten neue Einblicke in die Veränderungen der 
genetischen Profile von PBMo und ihrer residenten Nachkommen (DC und MΦ) in der 
Lunge unter nicht-entzündlichen Bedingungen. Gene, die in die Zellmigration von DC 
involviert sind, wurden auf Protein-Ebene bestätigt, während für den 5-HT2C Rezeptor 
auf rAMΦ gezeigt wurde, dass dieser funktionell aktiv ist und die zelluläre Antwort auf 
5-HT vermittelt. Diese Ergebnisse werden dazu beitragen die komplexen Beziehungen 
innerhalb des Monozyten-Makrophagen-Pools in der Lunge besser zu verstehen.  
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7. Appendix 
 
7.1 Reagents and source of supply 
 
Acetic acid        Merck, Germany 
Acetonitrile       Sigma-Aldrich, Germany 
Acrylamide solution, Rotiphorese Gel 30    Roth, Germany 
Agarose, low-melting      Sigma-Aldrich, Germany 
Ammonium persulfate (APS)     Promega, Germany 
Antibiotics (Penicillin/Streptomycin)    PAA Laboratories, Austria 
Bovine serum albumin (BSA)     Sigma-Aldrich, Germany 
Bromophenol blue       Sigma-Aldrich, Germany 
Calibrate beads       BD Biosciences, Germany 
Collagenase A       Roche, USA 
DC protein assay       Bio-Rad, Germany 
Distilled water      Braun, Germany  
DifcoTM skim milk       BD Pharmingen, Germany 
Dithiothreitol (DTT)       Invitrogen, UK 
DNAse        Serva, Germany 
dNTPs        Roche, USA 
DMEM medium       PAA Laboratories, Austria 
E.coli (0111:B4) ultrapure lipopolysaccharide (LPS) Calbiochem, Germany 
ECL Plus Western Blotting Detection System   Amersham Biosciences, UK 
EDTA        Biochrom, Germany 
ELISA kits        R&D Systems, Germany 
Ethanol        Riedel-de-Hän, Germany 
Ethidium bromide solution      Carl Roth, Germany 
Octagam (human IgG for Fc-blocking)   Octapharma, Germany 
Fetal calf serum (FCS)      PAA Laboratories, Austria 
Glycine        Sigma-Aldrich, Germany 
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Hank’s buffered saline solution (HBSS)    PAA laboratories, Austria 
HEPES buffer       Invitrogen, UK 
Hydrochloric acid (HCl)      Merck, Germany 
Isoflurane        Abbott, Germany 
Ketavet (Ketamine hydrochloride)     Pharmacia&Upjohn,Germany 
M-MLV reverse transcriptase     Invitrogen, UK 
N,N,N',N'-tetramethyl-ethane-1,2-diamine (TEMED) Sigma-Aldrich, Germany 
May-Grünwald/Giemsa staining solutions   Merck, Germany 
Paraformaldehyde (PFA)      Sigma-Aldrich, Germany 
Phosphate buffered saline (PBS)     PAA Laboratories, Austria 
Platinum Taq DNA polymerase     Invitrogen, UK 
Platinum SYBR Green qPCR SuperMix-UDG  Invitrogen, UK 
Protease inhibitor cocktail      Roche, Germany 
Random hexamers       Boehringer, Germany 
RNA amplification/labeling kit    Agilent, USA 
RNA isolation kit, RNeasy mini    Qiagen, Germany 
RNA isolation kit, Rneasy mikro    Qiagen, Germany 
RNase away        Molecular bioproducts, USA 
RNase inhibitor       Promega, USA 
Rompun (Xylazine hydrochloride)     Bayer, Germany 
RPMI-1640 medium       PAA laboratories, Austria 
Sodium chloride (0.9% NaCl solution)   Braun, Germany 
Sodium dodecyl sulfate (SDS)     Sigma-Aldrich, Germany 
β-mercaptoethanol       Sigma-Aldrich, Germany 
Tris         Carl Roth, Germany 
Trypan blue        Sigma-Aldrich, Germany 
Tween 20        Sigma-Aldrich, Germany 
5× first strand buffer for cDNA synthesis    Invitrogen, Germany 
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7.2 Equipment and source of supply 
 
Abbocath        Abbott, Germany 
Agilent Bioanalyzer 2100     Agilent Biosystems, USA 
Autoradiography film      GE Healthcare, UK 
BioDocAnalyse video system     Whatman-Biometra,Germany 
Cell culture incubator      Heraeus, Germany 
Cell-culture plates: 12, 24, 48 wells     BD Labware, USA 
Centrifuges       Heraeus, Germany 
Cytospin cytocentrifuge      Thermo Scientific, Germany 
Developing machine for X-ray films, Curix 60   Agfa, Germany 
EDTA coated tubes       Sarstedt, Germany 
Electrophoresis apparatus      Keutz, Germany 
ELISA reader        Molecular Devices, USA 
ELISA 96-well plate autowasher     Tecan, Germany 
Eppendorf tubes (0.6 ml; 1.5 ml; 2 ml)    Eppendorf, Germany 
Falcons (15 ml; 50 ml)     BD Falcon, USA 
FACSCanto        BD, Germany 
FACSDiva Software Package     BD, Germany 
FACSVantage       BD, Germany 
Filter tip        Greiner bio-one, Germany 
Filter units        Millipore, USA 
Film cassette        Cronex, Germany 
Fluorescence spectrophotometer    BD, USA 
Hybridization oven      Stovall, USA    
MACS cell isolation columns     Miltenyi Biotech, Germany 
Magnetic stir bar      Roth, Germany 
Microarray whole mouse genome 44k chip   Agilent, USA 
Microarray chip scanner Genepix 4000A   Molecular Devices, USA 
Mini Protean 3 cell       Bio-Rad, USA 
Mini spin centrifuge       Eppendorf, Germany 
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Mini Trans Blot       Bio-Rad, USA 
PCR tubes (0.2 ml)       Applied Biosystems, USA 
Pipettes       Gilson, France 
Pipette tips        BD, Germany 
Power supply        Biometra, Germany 
PVDF transfer membrane     GE Healthcare, UK 
Serological pipettes       BD Falcon, USA 
Sequence Detection System 7900 HT   Agilent Biosystems, USA 
Stereomicroscope       Leica, Germany 
Vortex machine       Scientific Industries,Germany 
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7.3 List of primers designed for qPCR 
 
Gene        forward primers 5′→ 3′   reverse primers 3′→ 5′ 
adam23 GCTCCACGTATCGGTCAACT CCCACGTCTGTATCATCGTCT 
adamts2 AGTGGGCCCTGAAGAAGTG CAGAAGGCTCGGTGTACCAT 
adam19 GCTGGTCTCCACCTTTCTGT CAGAACTGCCAACACGAAGA 
adam8 TAGACCTGATCCTCCCACCA ACCTTTGGCTCACCAGCTC 
mmp12 TGATGCAGCTGTCTTTGACC GTGGAAATCAGCTTGGGGTA 
mmp13 ATCCCTTGATGCCATTACCA AAGAGCTCAGCCTCAACCTG 
mmp14 GCCCAATGGGAAGACCTACT AGGGTACTCGCTGTCCACTG 
mmp19 TCCAGTGACTGCAAAACCTG AGTCGCCCTTGAAAGCATAA 
Itgae TGGCTCTCAATTATCCCAGAA CATGACCAGGACAGAAGCAA 
Itgam GGACTCTCATGCCTCCTTTG ACTTGGTTTTGTGGGTCCTG 
Itgb3 GTCCGCTACAAAGGGGAGAT TAGCCAGTCCAGTCCGAGTC 
Itgb7 GAGGACTCCAGCAATGTGGT GGGAGTGGAGAGTGCTCAAG 
itga4 TTCGGAAAAATGGAAAGTGG AACTTTTGGGTGTGGCTCTG 
itgax GAACCCCAAAAACCACCTTC CGACCACACTGGTCTTCTCC 
sell AAACGAAAGGCAGCTCTCTG CCCGTAATACCCTGCATCAC 
ccl2 AGCATCCACGTGTTGGCT C CCAGCCTACTCATTGGGATCAT 
ccl5 CTGCTTTGCCTAGGTCTCCCT CGGTTCCTTCGAGTGACAAAC 
ccr2 TCTTTGGTTTTGTGGGCAACA TCAGAGATGGCCAAGTTGAGC 
ccr7 GTGGTGGCTCTCCTTGTCAT GAAGCACACCGACTCGTACA 
gapdh TGGTGAAGGTCGGTGTGAAC TGAATTTGCCGTGAGTGGAG 
il18 CTGGCTGTGACCCTCTCTGT CTGGAACACGTTTCTGAAAGAAT 
htr2a ATAGCCGCTTCAACTCCAGA TCATCCTGTAGCCCGAAGAC 
htr2b GCAGATTTGCTGGTTGGATT ATAACCAGGCAGGACACAGG 
htr2c GTTCAATTCGCGGACTAAGG TCACGAACACTTTGCTTTCG 
gzma CTCCGTGGTGGAAAGGACT GGCGATCTCCACACTTCTCT 
gzmb CCAAAGACCAAACGTGCTTC GAAAGCACGTGGAGGTGAAC 
gzmk GATGCCAGAGGTCAAAAGGA GCGATGCCACATTTATAGCC 
gzmm TTAAAGGCTGGGAGCAAGAG GCAGGTTTTGGAGCTGAAAG 
gramd3 GATCGCCCTTCGTCTCTGC GATTCCGGAGTCTGGGATCC 
sphk1 GATGCATGAGGTGGTGAATG TGCTCGTACCCAGCATAGTG 
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Gene        forward primers 5′→ 3′          reverse primers 3′→ 5′ 
csf1 CCAAGAACTGCAACAACAGC CACTGCTAGGGGTGGCTTTA 
dpf1 TCCAAGAAGACTGGGTGTCC CACCGTGAACTGTAAACACGA 
nt5e CACCCTGAAGAAGGCTTTTG TCCAGGGCTTTCGGTTAATA 
il20rb CCAGCCTACGTGTGTGGAG TCAGCATGAAGCCAACAAAC 
myo1d ATGAGCTGAAACGCAAGGAC GGTGACGGTCAGTGACAAAA 
flrt3 TACCTTTGGCTGCCATCATT ACAGTGACCCGTTCCTATGC 
tgfbi CCATGCCTCCAGAAGAACTG CTCCGCTAACCAGGATTTCA 
ptges ATGCGCTGAAACGTGGAG GAAGCCGAGGAAGAGGAAAG 
icosl GGCATTCGTTTCCTTCATCA AGGCGTGGTCTGTAAGTTCAA 
slc7a2 AACCCTCTTCAGCCCCTCT GGACGCCATACGTGGTTAGA 
htra1 AGGGAAAGCTGTCACCAAGA TGACGGTCCTTCAGCTCTTT 
spp1 GCTTGGCTTATGGACTGAGG CGCTCTTCATGTGAGAGGTG 
actb ACCCTAAGGCCAACCGTG A CAGAGGCATACAGGGACAGCA 
hmbs TGGTGAAGGTCGGTGTGAAC TGAATTTGCCGTGAGTGGAG 
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